Benzochromene derivatives

Abstract
The present invention relates to benzochromene derivatives of the formula I in which the various parameters are as defined in the text, and to liquid-crystal media which comprise these compounds, and to the use of the media in electro-optical displays, in particular in VAN LCDs.
Description

The present invention relates to benzochromene derivatives, preferably mesogenic benzochromene derivatives, in particular liquid-crystalline benzochromene derivatives, and to liquid-crystalline media comprising these benzochromene derivatives. The present invention furthermore relates to liquid-crystal displays, in particular liquid-crystal displays addressed by means of an active matrix (AMDs or AM LCDs (“active matrix addressed liquid crystal displays”)) and very particularly so-called VAN (“vertically aligned nematic”) liquid-crystal displays, an embodiment of ECB (“electrically controlled birefringence”) liquid-crystal displays, in which nematic liquid crystals of negative dielectric anisotropy (Δε) are used.


In liquid-crystal displays of this type, the liquid crystals are used as dielectrics whose optical properties change reversibly on application of an electric voltage. Electro-optical displays which use liquid crystals as media are known to the person skilled in the art. These liquid-crystal displays use various electro-optical effects. The most common of these are the TN (“twisted nematic”) effect, with a homogeneous, virtually planar initial alignment of the liquid-crystal director and a nematic structure twisted by about 90°, the STN (“supertwisted nematic”) effect and the SBE (“super-twisted birefringence effect”) effect, with a nematic structure twisted by 180° or more. In these and similar electro-optical effects, liquid-crystalline media of positive dielectric anisotropy (As) are used.


Besides the said electro-optical effects, which require liquid-crystal media of positive dielectric anisotropy, there are other electro-optical effects which use liquid-crystal media of negative dielectric anisotropy, such as, for example, the ECB effect and its sub-forms DAP (“deformation of aligned phases”), VAN and CSH (“colour super homeotropics”).


An electro-optical effect having excellent, low, viewing-angle dependence of the contrast uses axially symmetric micropixels (ASMs). In this effect, the liquid crystal in each pixel is surrounded cylindrically by a polymer material. This mode is particularly suitable for combination with addressing through plasma channels. Thus, in particular, large-area PA (“plasma addressed”) LCDs having good viewing-angle dependence of the contrast can be achieved.


The IPS (“in plane switching”) effect, which has been increasingly employed recently, can use both dielectrically positive and dielectrically negative liquid-crystal media, similar to guest/host displays, which are able to employ dyes either in dielectrically positive or in dielectrically negative media, depending on the display mode used.


Since the operating voltage in liquid-crystal displays in general, i.e. including in displays based on these effects, should be as low as possible, use is made of liquid-crystal media having a large absolute value of the dielectric anisotropy, which generally predominantly and usually even very substantially consist of liquid-crystal compounds having a dielectric anisotropy having the corresponding sign, i.e. consist of compounds of positive dielectric anisotropy in the case of dielectrically positive media and of compounds of negative dielectric anisotropy in the case of dielectrically negative media. In the respective types of media (dielectrically positive or dielectrically negative), at most significant amounts of dielectrically neutral liquid-crystal compounds are typically employed. Liquid-crystal compounds having the sign of the dielectric anisotropy opposite to the dielectric anisotropy of the medium are generally employed in extremely small amounts, or not at all.


An exception here is formed by liquid-crystalline media for MIM (“metal-insulator-metal”) displays (Simmons, J. G., Phys. Rev. 155 No. 3, pp. 657-660 and Niwa, J. G. et al., SID 84 Digest, pp. 304-307, June 1984), in which the liquid-crystal media are addressed by means of an active matrix of thin-film transistors. In this type of addressing, which utilises the non-linear characteristic line of diode switching, it is not possible, in contrast to TFT displays, to charge a storage capacitor together with the electrodes of the liquid-crystal display elements (pixels). A reduction in the effect of voltage drop during the addressing cycle therefore requires the highest possible base value of the dielectric constant. In dielectrically positive media, as employed, for example, in MIM-TN displays, the dielectric constant perpendicular to the molecular axis (ε195 ) must therefore be as large as possible, since it determines the base capacitance of the pixel. To this end, as described, for example, in WO 93/01253, EP 0 663 502 and DE 195 21 483, compounds of negative dielectric anisotropy are simultaneously employed in addition to dielectrically positive compounds in the dielectrically positive liquid-crystal media.


A further exception is formed by STN displays in which, for example in accordance with DE 41 00 287, dielectrically positive liquid-crystal media comprising dielectrically negative liquid-crystal compounds are employed in order to increase the steepness of the electro-optical characteristic line.


The pixels of the liquid-crystal displays can be addressed directly, time-sequentially, i.e. in time multiplex mode, or by means of a matrix of active elements having nonlinear electric characteristic lines.


The most common AMDs to date use discrete active electronic switching elements, such as, for example, three-pole switching elements, such as MOS (“metal oxide silicon”) transistors or thin-film transistors (TFTs) or varistors or 2-pole switching elements, such as, for example, MIM (“metal insulator metal”) diodes, ring diodes or back-to-back diodes. In TFTs, various semiconductor materials, predominantly silicon, but also cadmium selenide, are used. In particular, amorphous silicon or polycrystalline silicon is used.


In accordance with the present application, preference is given to liquid-crystal displays having an electric field perpendicular to the liquid-crystal layer and liquid-crystal media of negative dielectric anisotropy (Δε<0). In these displays, the edge alignment of the liquid crystals is homeotropic. In the fully switched-through state, i.e. on application of a correspondingly high electric voltage, the liquid-crystal director is aligned parallel to the layer plane.


Cyclic lactones of the formula
embedded image

    • in which
    • —X—Y— is —CO—O— or —O—CO—


      are disclosed in JP 2001-026 587 (A). These compounds are characterised by broad smectic phases and are proposed for use in ferroelectric liquid-crystal mixtures in JP 2001-026 587 (A).


U.S. Pat. No. 5,648,021 discloses fluorinated phenanthrenes of the formula
embedded image


and fluorinated 9,1 0-dihydrophenanthrenes of the formula
embedded image


These also have broad smectic phases and are likewise proposed for use in ferroelectric liquid-crystal mixtures.


DE 100 64 995 presents fluorinated phenanthrenes of the formula
embedded image

    • in which
    • L1 and L2 are each, independently of one another, H or F,


and proposes them for use in nematic liquid-crystal mixtures, in particular for ECB displays. The example compounds in which L1 and L2 are both H and which contain one alkyl end group and one alkoxy end group have an only slightly negative Δε, whereas the example compounds in which L1 and L2 are both F and which contain one alkoxy end group, although having a more negative Δε, generally have greater rotational viscosity, significantly lower solubility and in addition in most cases inadequate UV stability.


It is thus evident that there is both a demand for further mesogenic compounds and also, in particular, a demand for liquid-crystal media of negative dielectric anisotropy having a large absolute value of the dielectric anisotropy, a value of the optical anisotropy (Δn) corresponding to the particular application, a broad nematic phase, good stability to UV, heat and electric voltage and low rotational viscosity.


This is achieved through the use of the mesogenic compounds of the formula I according to the invention
embedded image

    • in which
    • Y is —CO—, —CS—, —CH2—, —CF2— or —CHF—, preferably —CF2—,
    • L1 and L2 are each, independently of one another, H, F, Cl or —CN, preferably H or F, preferably at least one of L1 and L2 is F, particularly preferably L1 and L2 are both F,
      embedded image

      are each, independently of one another, and, if present more than once, also independently of one another,
    • (a) a trans-1,4-cyclohexylene radical, in which, in addition, one or two non-adjacent CH2 groups may be replaced by —O— and/or —S—,
    • (b) a 1,4-cyclohexenylene radical,
    • (c) a 1,4-phenylene radical, in which, in addition, one or two non-adjacent CH groups may be replaced by N, or
    • (d) a radical selected from the group consisting of 1,4-bicyclo-[2.2.2]octylene, 1,3-bicyclo[1.1.1]pentylene, spiro[3.3]-heptane-2,4-diyl, piperidine-1,4-diyl, naphthalene-2,6-diyl, decahydronaphthalene-2,6-diyl and 1,2,3,4-tetrahydro-naphthalene-2,6-diyl,
    • preferably
      embedded image
    • R1 and R2 are each, independently of one another, H, halogen, —CN, —SCN, —SF5, —CF3, —CHF2, —CH2F, —OCF3, —OCHF2, or an alkyl group having from 1 to 15 carbon atoms which is monosubstituted by CN or CF3 or at least monosubstituted by halogen and in which, in addition, one or more CH2 groups may each, independently of one another, be replaced by —O—, —S—, —CH=CH—, —CF=CF—, —CF═CH—, —CH═CF—,
      embedded image

      —CO—, —CO—O—, —O—CO— or —O—CO—O— in such a way that neither O nor S atoms are linked directly to one another,
    • preferably one of
    • R1 and R2 is alkyl or alkoxy having from 1 to 12 carbon atoms, alkoxyalkyl, alkenyl or alkenyloxy having from 2 to 12 carbon atoms and the other, independently of the first, is likewise alkyl or alkoxy having from 1 to 12 carbon atoms, alkoxyalkyl, alkenyl or alkenyloxy having from 2 to 12 carbon atoms or alternatively F, Cl, Br, —CN, —SCN, —SF5, —CF3, —CHF2, —CH2F, —OCF3 or —OCHF2,
    • Z1 and Z2 are each, independently of one another, —CH2—CH2—, —CF2—CF2—, —CF2—CH2—, —CH2—CF2—, —CH=CH—, —CF═CF—, —CF=CH—, —CH═CF—, —C≡C—, —COO—, —OCO—, —CH2O—, —OCH2—, —CF2O—, —OCF2—, or a combination of two of these groups, where no two 0 atoms are bonded to one another,
    • preferably —(CH2)4—, —CH2—CH2—, —CF2—CF2—, —CH═CH—, —CF═CF—, —C≡C—, —CH2O—, —CF2O— or a single bond, particularly preferably —CH2O—, —CH2—CH2—, —CF2—CF2—, —CF═CF—, —CF2O— or a single bond, and
    • n and m are each 0, 1 or 2, where
    • n+m is 0, 1, 2 or 3, preferably 0, 1 or 2, particularly preferably 0 or 1,
    • with the proviso that, if Y is —CO—, at least one of L1 and L2 is not H.


Particular preference is given to liquid-crystal compounds of the formula I of the sub-formulae 1-1 to 1-3
embedded image

in which the parameters are as defined above under the formula I, and

    • L1 and L2 are preferably both F.


Preference is given to compounds of the formula 1, preferably selected from the group consisting of the compounds of the formulae I-1 to I-3, in which


the sum n+m is 0 or 1, preferably 0.


A preferred embodiment is represented by the compounds of the formula I in which the sum n+m is 1 and preferably


m or n is,
embedded image


Z2 is preferably —(CH2)4—, —CH2—CH2—, —CF2—CF2—, —CH═CH—, —CF═CF—, —C≡C—, —O—CH2—, —O—CF2— or a single bond, particularly preferably —O—CH2—, —CH2—CH2—, —CF2—CF2—, —CF═CF—, —O—CF2— or a single bond,


and L1, L2, R1 and R2 are as defined above under the formula I, and L1 and L2 are preferably both F.


Particular preference is given to compounds of the formula I, preferably selected from the group consisting of the compounds of the formulae I-1 to I-3, in which


n and m are both 0, and


L1, L2, R1 and R2 are as defined above under the corresponding formula, and L1 and L2 are preferably both F.


Compounds of the formula I containing branched wing groups R1 and/or R2 may occasionally be of importance owing to better solubility in the usual liquid-crystalline base materials, but in particular as chiral dopants if they are optically active. Smectic compounds of this type are suitable as components of ferroelectric materials. Compounds of the formula I having SA phases are suitable, for example, for thermally addressed displays.


If R1 and/or R2 is an alkyl radical and/or an alkoxy radical, this may be straight-chain or branched. It is preferably straight-chain, has 2, 3, 4, 5, 6 or 7 carbon atoms and accordingly is preferably ethyl, propyl, butyl, pentyl, hexyl, heptyl, ethoxy, propoxy, butoxy, pentoxy, hexyloxy or heptyloxy, furthermore methyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetra-decyl, pentadecyl, methoxy, octyloxy, nonyloxy, decyloxy, undecyloxy, dodecyloxy, tridecyloxy or tetradecyloxy.


Oxaalkyl or alkoxyalkyl is preferably straight-chain 2-oxapropyl (=methoxy-methyl), 2-(=ethoxymethyl) or 3-oxabutyl (=2-methoxyethyl), 2-, 3- or 4-oxapentyl, 2-, 3-, 4- or 5-oxahexyl, 2-, 3-, 4-, 5- or 6-oxaheptyl, 2-, 3-, 4-, 5-, 6- or 7-oxaoctyl, 2-, 3-, 4-, 5-, 6-, 7- or 8-oxanonyl, or 2-, 3-, 4-, 5-, 6-, 7-, 8- or 9-oxadecyl.


If R1 and/or R2 is an alkyl radical in which one CH2 group has been replaced by —CH═CH—, this may be straight-chain or branched. It is preferably straight-chain and has from 2 to 10 carbon atoms. Accordingly, it is in particular vinyl, prop-1- or -2-enyl, but-1-, -2- or -3-enyl, pent-1-, -2-, -3- or -4-enyl, hex-1-, -2-, -3-, -4- or-5-enyl, hept-1-, -2-, -3-, -4-, -5-or -6-enyl, oct-1-, -2-, -3-, -4-, -5-, -6- or -7-enyl, non-1-, -2-, -3-, -4-, -5-, -6-, -7- or -8-enyl, or dec-1-, -2-, -3-, -4-, -5-, -6-, -7-, -8- or -9-enyl.


If R1 and/or R2 is an alkyl radical in which one CH2 group has been replaced by —O— and one has been replaced by —CO—, these are preferably adjacent. These thus contain an acyloxy group —CO—O— or an oxycarbonyl group —O—CO—. These are preferably straight-chain and have from 2 to 6 carbon atoms. Accordingly, they are in particular acetoxy, propionyloxy, butyryloxy, pentanoyloxy, hexanoyloxy, acetoxymethyl, propionyloxymethyl, butyryloxymethyl, pentanoyloxymethyl, 2-acetoxyethyl, 2-propionyloxyethyl, 2-butyryloxyethyl, 3-acetoxypropyl, 3-propionyloxypropyl, 4-acetoxybutyl, methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, butoxycarbonyl, pentoxycarbonyl, methoxycarbonylmethyl, ethoxycarbonylmethyl, propoxycarbonylmethyl, butoxyca rbonylmethyl, 2-(methoxyca rbonyl)ethyl, 2-(ethoxycarbonyl)ethyl, 2-(propoxycarbonyl)ethyl, 3-(methoxycarbonyl)propyl, 3-(ethoxycarbonyl)propyl or 4-(methoxycarbonyl)butyl.


If R1 and/or R2 is an alkyl radical in which one CH2 group has been replaced by unsubstituted or substituted —CH═CH— and an adjacent CH2 group has been replaced by CO or CO—O or O—CO, this may be straight-chain or branched. It is preferably straight-chain and has from 4 to 13 carbon atoms. Accordingly, it is in particular acryloyloxymethyl, 2-acryl-oyloxyethyl, 3-acryloyloxypropyl, 4-acryloyloxybutyl, 5-acryloyloxypentyl, 6-acryloyloxyhexyl, 7-acryloyloxyheptyl, 8-acryloyloxyoctyl, 9-acryloyloxy-nonyl, 10-acryloyloxydecyl, methacryloyloxymethyl, 2-methacryloyloxyethyl, 3-methacryloyloxypropyl, 4-methacryloyloxybutyl, 5-methacryloyloxypentyl, 6-methacryloyloxyhexyl, 7-methacryloyloxyheptyl, 8-methacryloyloxyoctyl or 9-methacryloyloxynonyl.

    • If R1 and/or R2 is an alkyl or alkenyl radical which is monosubstituted by CN or CF3, this radical is preferably straight-chain. The substitution by CN or CF3 is in any desired position.


If R1 and/or R2 is an alkyl or alkenyl radical which is at least monosubstituted by halogen, this radical is preferably straight-chain, and halogen is preferably F or Cl. In the case of polysubstitution, halogen is preferably F. The resultant radicals also include perfluorinated radicals. In the case of monosubstitution, the fluorine or chlorine substituent may be in any desired position, but is preferably in the o-position.


Branched groups generally contain not more than one chain branch. Preferred branched radicals R1 are isopropyl, 2-butyl (=1-methylpropyl), isobutyl (=2-methylpropyl), 2-methylbutyl, isopentyl (=3-methylbutyl), 2-methylpentyl, 3-methylpentyl, 2-ethylhexyl, 2-propylpentyl, isopropoxy, 2-methylpropoxy, 2-methylbutoxy, 3-methylbutoxy, 2-methylpentoxy, 3-methylpentoxy, 2-ethylhexyloxy, 1-methylhexyloxy and 1-methyl-heptyloxy.


If R1 and/or R2 is an alkyl radical in which two or more CH2 groups have been replaced by —O— and/or —CO—O—, this may be straight-chain or branched. It is preferably branched and has from 3 to 12 carbon atoms. Accordingly, it is in particular biscarboxymethyl, 2,2-biscarboxyethyl, 3,3-biscarboxypropyl, 4,4-biscarboxybutyl, 5,5-biscarboxypentyl, 6,6-bis-carboxyhexyl, 7,7-biscarboxyheptyl, 8,8-b isca rboxyoctyl, 9,9-biscarboxy-nonyl, 10,10-biscarboxydecyl, bis(methoxycarbonyl)methyl, 2,2-bis-(methoxycarbonyl)ethyl, 3,3-bis(methoxycarbonyl)propyl, 4,4-bis(methoxy-carbonyl)butyl, 5,5-bis(methoxycarbonyl)pentyl, 6,6-bis(methoxycarbonyl)-hexyl, 7,7-bis(methoxycarbonyl)heptyl, 8,8-bis(methoxycarbonyl)octyl, bis(ethoxycarbonyl)methyl, 2,2-bis(ethoxycarbonyl)ethyl, 3,3-bis(ethoxy-carbonyl)propyl, 4,4-bis(ethoxycarbonyl)butyl or 5,5-bis(ethoxycarbonyl)-hexyl.


Particular preference is given to compounds of the formula I in which n=0 or 1 and m=0 and R1 is methyl, ethyl, propyl, butyl, pentyl, vinyl, 1E-propenyl, 1E-butenyl or 1E-pentenyl, and to media comprising these compounds. Of these compounds, the alkyl-substituted compounds are particularly preferably employed.


The compounds of the formula I are prepared in accordance with the following schemes (Schemes I to XX).


The cyclic lactones can be prepared in accordance with Scheme I by intramolecular cyclisation of aryl phenyl esters which have been halogenated in a suitable manner by coupling reactions of the Ullmann type (Houben Weyl, Methoden der Organischen Chemie [Methods of Organic Chemistry], New York, 1993). They can alternatively be obtained by palladium-catalysed intramolecular cross-coupling reactions as shown in Scheme II and Scheme III.


Alternatively, the cross-coupling can also be carried out in a first step with the correspondingly protected phenols and carboxylic acid esters, as shown in Scheme IIIa using the example of a Negishi reaction (Negishi, E. et al., J. Org. Chem. (1977) 42, pp. 1821-1823).
embedded image

in which, as in Schemes Ia to Id, II, III, IIIa, IV to XX, unless explicitly stated otherwise,


R and R′ are each, independently of one another, as defined above for
embedded image

    • under the formula I, and


Hal is halogen, preferably Br or 1.


A: Hasan, I. et al., Chem. Rev. (2002), 102, pp. 1359-1469,


B: Hennings, D. D. et al., Org. Lett. (1999), 1, pp. 1205-1208.


The ester precursors are synthesised by standard reactions (Houben-Weyl) from commercially available 4-bromo-3-fluoro-1-iodobenzene or (in the case where R=methyl from 4-bromo-2-fluorotoluene, or from 4-bromo-2-fluorophenol (ABCR, Karlsruhe, Germany)).


Alkyl side chains are advantageously introduced into the precursors by Sonogashira coupling as shown in Scheme Ia.


Precursors containing alkoxy side chains are advantageously obtained in accordance with Scheme Ib.


The two types of intermediate obtained in accordance with Scheme Ia or Ib can, as shown in Scheme Ic by way of example for the alkyl compounds, be converted either into the phenol or into the carboxylic acid and subsequently esterified.
embedded imageembedded imageembedded image


The bromophenol can be protected and converted into the boronic acid in accordance with Scheme Id for subsequent Suzuki couplings.
embedded imageembedded image


C: Bringmann, G. et al., Org. Synth. (2002), 79, pp. 72-83.
embedded image


D: Alo, B. I. et al., J. Org. Chem. (1991), 56, pp. 3763-3768.


The lactones (Ia) can, as shown in Scheme IV, be converted, analogously to EP 1 061 113, into the benzochromenes (1b) or alternatively, using Lawesson's reagent followed by reaction with DAST, into the difluorobenzochromenes (1c) (Bunelle, W. H. et al., J. Org. Chem. (1990), 55, pp. 768-770).


Alternatively, the lactones (1a) can, in accordance with Scheme V (Ringom, R. and Bennecke, T., Acta. Chem. Scand. (1999), 53, pp. 41-47), be reacted with LiAlH4 in THF and subsequently reacted with DAST to give the fluorobenzochromenes (Id).


The above-mentioned alternative synthesis in which the cross-coupling is carried out in a first step with the correspondingly protected phenols and carboxylic acid esters is shown in Scheme IIIa on p. 16 using the example of a Negishi reaction.
embedded image

    • in which
    • PG is a protecting group,
    • X is halogen, preferably Br,
    • X1 and X2, independently of one another, are halogen,
    • X1 is preferably Cl, Br or I, particularly preferably Br or I, very particularly preferably Br,
    • R″ is alkyl, preferably methyl, and
    • R and R′ are each, independently of one another, as defined above for Scheme I.


After removal of the protecting group, the lactones can be obtained, for example, by simple heating in an inert solvent or by treatment with an acid or base.
embedded imageembedded image

Compounds of the formula I in which
embedded image

    • are R1, R2,
      embedded image

      in which the
      embedded image

      rings may also be heterocyclic rings,


can be obtained in accordance with Schemes VI to XX.
embedded imageembedded imageembedded imageembedded image


4-Bromo-3-fluoro-1-iodobenzene and 4-bromo-2-fluorophenol are likewise suitable as synthetic building blocks for a multiplicity of derivatives which can be converted into the corresponding target compounds analogously to the reaction sequences shown in Schemes I-V.


Cyclohexyl derivatives are obtained, for example, in accordance with Scheme X. Metallation of 4-bromo-3-fluoro-1-iodobenzene using n-butyllithium and addition onto cyclohexanones gives phenylcyclohexanols, from which 4-bromo-2-fluoro-1-cyclohexylbenzene derivatives are obtained after elimination of water and hydrogenation.
embedded image


Aryl derivatives are obtained, for example, in accordance with Scheme XI. Direct Suzuki coupling of 4-bromo-3-fluoro-1-iodobenzene with the corresponding boronic acids enables the preparation of 1-aryl-4-bromo-2-fluoro derivatives.
embedded image


Sonogashira coupling of 4-bromo-3-fluoro-1-iodobenzene with phenylacetylenes gives, as shown in Scheme XII, 4-bromo-2-fluorotolans. These can, as shown in Scheme XIII, either be hydrogenated to give ethylene-bridged compounds or converted into diketones by the method of V. O. Rogatchov, V. D. Filimonov, M. S. Yusubov, Synthesis (2001), 7, 1001-1003, from which tetrafluoroethylene-bridged compounds are obtained by reaction with sulfur tetrafluoride.
embedded imageembedded image


From 4-bromo-2-fluorophenol, hydroxyl compounds and triflates can be obtained as synthetic building blocks in accordance with Scheme XIV.


4-Bromo-2-fluorophenol is protected here using a suitable protecting group “PG” (for example benzyl); corresponding reaction in accordance with Schemes I to V and subsequent removal of the protecting group (for example by hydrogenation for benzyl as PG) enables the preparation of phenols and from these triflates (trifluoromethanesulfonates, TfO-).
embedded image

    • in which, as in Schemes XV to XX,
    • G is Y—O or O—Y, and
    • Y is as defined above under the formula I.


The phenols obtained in this way can be converted into esters and ethers in accordance with Scheme XV.
embedded image

    • in which R, as in Schemes XVI to XX, is as defined for R1 under the formula I.


CF2O-bridged compounds are obtained in accordance with WO 02/48 073 and WO 01/64 667, as shown in Scheme XVI.
embedded image


Suzuki coupling of the triflates obtained in accordance with Scheme XIV with etheneboronic acids enables the preparation of stilbenes (Scheme XVII).
embedded image


Difluorostilbenes are accessible analogously by Stille reaction as described by L. Lu, D. J. Burton, Tetrahedron Lett. 1997, 38, 7673-7676, (Scheme XVIII).
embedded image


Carbonylation of triflates by the method of S. Cacchi, P. G. Ciattini, E. Morera, G. Ortar, Tetrahedron Lett. (1986), 27, 3931-3934 gives carboxylic acid esters (Scheme XIX). After saponification to the corresponding carboxylic acids, reaction thereof with-phenols enables the preparation of, for example, phenyl esters.
embedded image


The carboxylic acid esters obtained in accordance with Scheme XIX can be converted into difluorobenzyl ethers in accordance with WO 02/480 73 and WO 01/64 667, as shown in Scheme XX.
embedded image


Examples of structures of preferred compounds of the formula I, in which R and R1 have the respective meaning given for R1 and R2 respectively under the formula I, are given on the following pages.
embedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded image


The liquid-crystal media according to the invention comprise one or more compounds of the formula I.


In a preferred embodiment, the liquid-crystal media in accordance with the present invention comprise

    • a) one or more dielectrically negative compound(s) of the formula I
      embedded image
    • in which
    • Y is —CO—, —CS—, —CH2—, —CF2— or —CHF—, preferably —CF2—,
    • L1 and L2 are each, independently of one another, H, F, Cl or —CN, preferably H or F, preferably at least one of L1 and L2 is F, particularly preferably L1 and L2 are both F,
      embedded image

      are each, independently of one another, and, if present more than once, also independently of one another,
    • (a) a trans-1,4-cyclohexylene radical, in which, in addition, one or two non-adjacent CH2 groups may be replaced by —O— and/or —S—,
    • (b) a 1,4-cyclohexenylene radical,
    • (c) a 1,4-phenylene radical, in which, in addition, one or two non-adjacent CH groups may be replaced by N, or
    • (d) a radical selected from the group consisting of 1,4-bicyclo[2.2.2]octylene, 1,3-bicyclo[1.1.1]pentylene, spiro[3.3]heptane-2,4-diyl, piperidine-1,4-diyl, naphthalene-2,6-diyl, decahydronaphthalene-2,6-diyl and 1,2,3,4-tetrahydronaphthalene-2,6-diyl, preferably
      embedded image
    • R1 and R2 are each, independently of one another, H, halogen, —CN, —SCN, —SF5, —CF3, —CHF2, —CH2F, —OCF3, —OCHF2, or an alkyl group having from 1 to 15 carbon atoms which is monosubstituted by CN or CF3 or at least monosubstituted by halogen and in which, in addition, one or more CH2 groups may each, independently of one another, be replaced by —O—, —S—, —CH═CH—, —CF═CF—, —CF=CH—, —CH═CF—,
      embedded image

      —CO—, —CO—O—, —O—CO— or —O—CO—O— in such a way that neither O nor S atoms are linked directly to one another,
    • preferably one of
    • R1 and R2 is alkyl or alkoxy having from 1 to 12 carbon atoms, alkoxyalkyl, alkenyl or alkenyloxy having from 2 to 12 carbon atoms and the other, independently of the first, is likewise alkyl or alkoxy having from 1 to 12 carbon atoms, alkoxyalkyl, alkenyl or alkenyloxy having from 2 to 12 carbon atoms or alternatively F, Cl, Br, —CN, —SCN, —SF5, —CF3, —CHF2, —CH2F, —OCF3 or —OCHF2,
    • Z1 and Z2 are each, independently of one another, —CH2—CH2—, —CF2—CF2—, —CF2—CH2—, —CH2—CF2—, —CH═CH—, —CF═CF—, —CF=CH—, —CH═CF—, —C≡C—, —COO—, —OCO—, —CH2O—, —OCH2—, —CF2O—, —OCF2—, or a combination of two of these groups, where no two O atoms are bonded to one another,
    • preferably —(CH2)4—, —CH2—CH2—, —CF2—CF2—, —CH═CH—, —CF═CF—, —C≡C—, —CH2O—, —CF2O— or a single bond,
    • particularly preferably —CH2O—, —CH2—CH2—, —CF2—CF2—, —CF═CF—, —CF2O— or a single bond, and
    • n and m are each 0, 1 or 2, where
    • n+m is 0, 1, 2 or 3, preferably 0, 1 or 2, particularly preferably 0 or 1,
    • b) one or more dielectrically negative compound(s) of the formula II
      embedded image
    • in which
    • R21 and R22 are each, independently of one another, as defined above for R1 under the formula I,
    • Z21 and Z22 are each, independently of one another, as defined above for Z1 under the formula I,
    • at least one of the rings present
      embedded image

      preferably
      embedded image

      and
      embedded image

      is
      embedded image

      and the others are each, independently of one another,
      embedded image

      preferably
      embedded image

      particularly preferably
      embedded image

      if present, is
      embedded image

      very particularly preferably one of
      embedded image

      and, if present,
      embedded imageembedded image

      preferably
      embedded image
    • L21 and L21 are both C—F or one of the two is N and the other is C—F, preferably both are C—F, and
    • I is 0, 1 or 2, preferably 0 or 1;


      and optionally
    • c) one or more dielectrically neutral compound(s) of the formula III
      embedded image
    • in which
    • R31 and R32 are each, independently of one another, as defined above for R1 under the formula I, and
    • Z31, Z32 and Z33 are each, independently of one another, —CH2CH2—, —CH═CH—, —COO— or a single bond,
      embedded image

      are each, independently of one another,
      embedded image
    • o and p, independently of one another, are 0 or 1, but preferably
    • R31 and R32 are each, independently of one another, alkyl or alkoxy having 1-5 carbon atoms or alkenyl having 2-5 carbon atoms,
      embedded image

      are each, independently of one another,
      embedded image

      and very particularly preferably at least two of these rings are
      embedded image

      where very particularly preferably two adjacent rings, preferably
      embedded image

      are linked directly.


The liquid-crystal media preferably comprise one or more compounds of the formula I which do not contain a biphenyl unit.


The liquid-crystal media particularly preferably comprise one or more compounds of the formula I


in which two adjacent rings, preferably
embedded image

are linked directly.


In a preferred embodiment, which may be identical with the embodiments just described, the liquid-crystal media comprise one or more compounds selected from the group consisting of the compounds of the formula I-3.


The liquid-crystal medium preferably comprises one or more compounds selected from the group consisting of the compounds of the formulae II-1 to II-3
embedded image

in which


R21, R22, Z12, Z22,
embedded image

and and I are each as defined above under the formula II. R21 is preferably alkyl, preferably having 1-5 carbon atoms, R is preferably alkyl or alkoxy, preferably each having from 1 to 5 carbon atoms, and Z22 and Z21, if present, are preferably a single bond.


The liquid-crystal medium particularly preferably comprises one or more compounds selected from the group consisting of the compounds of the formulae III-1 to III-3:
embedded image

    • in which R31, R32, R31, Z32 embedded image

      and are each as
    • defined above under the formula III.


The liquid-crystal medium especially preferably comprises one or more compounds selected from the group consisting of the compounds of the formulae III-1a to III-1d, III-1e, III-2a to III-2g, III-3a to III-3d and III-4a:
embedded image

in which n and m are each, independently of one another, from 1 to 5, and o and p are each, independently both thereof and of one another, from 0 to 3,
embedded image

in which R31 and R33 are each as defined above under the formula III, preferably as defined above under the formula III-1, and the phenyl rings, in particular in the compounds III-2g and III-3c, may optionally be fluorinated, but not in such a way that the compounds are identical with those of the formula II and its sub-formulae. R31 is preferably n-alkyl having from 1 to 5 carbon atoms, particularly preferably having from 1 to 3 carbon atoms, and R32 is preferably n-alkyl or n-alkoxy having from 1 to 5 carbon atoms or alkenyl having from 2 to 6 carbon atoms. Of these, especial preference is given to compounds of the formulae III-1a to III-1d.


Preferred fluorinated compounds of the formulae III-2g and III-3c are the compounds of the formulae III-2g′ and III-3c′
embedded image


in which R and R are each as defined above under the formula III, preferably as defined above under the formula III-2g or III-3c.


In the present application, unless expressly stated otherwise, the term compounds is taken to mean both one compound and a plurality of compounds.


The liquid-crystal med.ia according to the invention preferably have nematic phases of in each case from at least −20° C. to 80° C., preferably from −30° C. to 85° C. and very particularly preferably from −40° C. to 100° C. The term “have a nematic phase” here is taken to mean firstly that no smectic phase and no crystallisation are observed at low temperatures at the corresponding temperature and secondly also that no clearing occurs on heating from the nematic phase. The investigation at low temperatures is carried out in a flow viscometer at the corresponding temperature and checked by storage in test cells having.a layer thickness corresponding to the electro-optical application for at least 100 hours. The storage stability (tstore (T)) at the corresponding temperature (T) is quoted as the time up to which all three test cells show no change. At high temperatures, the clearing point is measured in capillaries by conventional methods.


Furthermore, the liquid-crystal media according to the invention are characterised by low optical anisotropy values.


The term “alkyl” preferably covers straight-chain and branched alkyl groups having from 1 to 7 carbon atoms, in particular the straight-chain groups methyl, ethyl, propyl, butyl, pentyl, hexyl and heptyl. Groups having from 2 to 5 carbon atoms are generally preferred.


The term “alkenyl” preferably covers straight-chain and branched alkenyl groups having from 2 to 7 carbon atoms, in particular the straight-chain groups. Particularly preferred alkenyl groups are C2- to C7-1 E-alkenyl, C4- to C7-3E-alkenyl, C5- to C7-4-alkenyl, C6- to C7-5-alkenyl and C7-6-alkenyl, in particular C2- to C7-1E-alkenyl, C4- to C7-3E-alkenyl and C5- to C7-4-alkenyl. Examples of further preferred alkenyl groups are vinyl, 1E-propenyl, 1E-butenyl, 1E-pentenyl, 1E-hexenyl, 1E-heptenyl, 3-butenyl, 3E-pentenyl, 3E-hexenyl, 3E-heptenyl, 4-pentenyl, 4Z-hexenyl, 4E-hexenyl, 4Z-heptenyl, 5-hexenyl, 6-heptenyl and the like. Groups having up to 5 carbon atoms are generally preferred.


The term “fluoroalkyl” preferably covers straight-chain groups having a terminal fluorine, i.e. fluoromethyl, 2-fluoroethyl, 3-fluoropropyl, 4-fluoro-butyl, 5-fluoropentyl, 6-fluorohexyl and 7-fluoroheptyl. However, other positions of the fluorine are not excluded.


The term “oxaalkyl” or “alkoxyalkyl” preferably covers straight-chain radicals of the formula CnH2n+1—O—(CH2)m, in which n and m are each, independently of one another, from 1 to 6. n is preferably 1 and m is preferably from 1. to 6.


Compounds containing a vinyl end group and compounds containing a methyl end group have low rotational viscosity.


In the present application, the term dielectrically positive compounds means compounds having a Δε of >1.5, dielectrically neutral compounds means those in which −1.5≦Δε≦1.5, and dielectrically negative compounds means those having a Δε of <−1.5. The dielectric anisotropy of the compounds is determined here by dissolving 10% of the compounds in a liquid-crystalline host and determining the capacitance of this mixture at 1 kHz in at least one test cell with a layer thickness of about 20 μm having a homeotropic surface alignment and at least one test cell with a layer thickness of about 20 μm having a homogeneous surface alignment. The measurement -voltage is typically from 0.5 V to 1.0 V, but is always less than the capacitive threshold of the respective liquid-crystal mixture.


The host mixture used for determining the applicationally relevant physical parameters is ZLI-4792 from Merck KGaA, Germany. As an exception, the determination of the dielectric anisotropy of dielectrically negative compounds is carried out using ZLI-2857, likewise from Merck KGaA, Germany. The values for the respective compound to be investigated are obtained from the change in the properties, for example the dielectric constants, of the host mixture after addition of the compound to be investigated and extrapolation to 100% of the compound employed.


The concentration employed for the compound to be investigated is 10%. If the solubility of the compound to be investigated is inadequate for this purpose, the concentration employed is, by way of exception, halved, i.e. reduced to 5%, 2.5%, etc., until the concentration is below the solubility limit.


The term threshold voltage usually relates to the optical threshold for 10% relative contrast (V10). In relation to the liquid-crystal mixtures of negative .dielectric anisotropy, however, the term threshold voltage is used in the present application for the capacitive threshold voltage (V0), also known as the Freedericksz threshold, unless explicitly stated otherwise.


All concentrations in this application, unless explicitly stated otherwise, are given in per cent by weight and relate to the corresponding mixture as a whole. All physical properties are and have been determined in accordance with “Merck Liquid Crystals, Physical Properties of Liquid Crystals”, status November 1997, Merck KGaA, Germany, and apply to a temperature of 20° C., unless explicitly stated otherwise. An is determined at 589 nm and Δε at 1 kHz.


In the case of the liquid-crystal media of negative dielectric anisotropy, the threshold voltage was determined as the capacitive threshold V0 in cells with a liquid-crystal layer aligned homeotropically by means of lecithin.


The liquid-crystal media according to the invention may, if necessary, also comprise further additives and optionally also chiral dopants in the conventional amounts. The amount of these additives employed is in total from 0% to 10%, based on the amount of the mixture as a whole, preferably from 0.1% to 6%. The concentrations of the individual compounds employed are in each case preferably from 0.1 to 3%. The concentration of these and similar additives is not taken into account when indicating the concentrations and the concentration ranges of the liquid-crystal compounds in the liquid-crystal media.


The compositions consist of a plurality of compounds, preferably from 3 to 30, particularly preferably from 6 to 20 and very particularly preferably from 10 to 16 compounds, which are mixed in a conventional manner. In general, the desired amount of the components used in lesser amount is dissolved in the components making up the principal constituent, advantageously at elevated temperature. If the selected temperature is above the clearing point of the principal constituent, the completion of the dissolution process is particularly easy to observe. However, it is also possible to prepare the liquid-crystal mixtures in other conventional ways, for example using premixes or from a so-called “multibottle” system.


By means of suitable additives, the liquid-crystal phases according to the invention can be modified in such a way that they can be employed in any type of display and in particular of ECB display and IPS display that has been disclosed hitherto.


The examples below serve to illustrate the invention without representing a restriction. In the examples, the melting point T(C,N), the transition from the smectic (S) phase to the nematic (N) phase T(S,N) and the clearing point T(N,I) of a liquid-crystal substance are indicated in degrees Celsius. The various smectic phases are characterised by corresponding suffixes.


The percentages above and below are, unless explicitly stated otherwise, percent by weight, and the physical properties are the values at 20° C., unless explicitly stated otherwise.


All the temperature values indicated in this application are ° C. and all temperature differences are correspondingly differential degrees, unless explicitly stated otherwise.


In the synthesis examples and schemes, the abbreviations have the following meanings:

  • BuLi n-butyllithium,
  • DAST diethylaminosulfur trifluoride,
  • DCC dicyclohexylcarbodiimide,
  • DMAP dimethylaminopyridine,
  • DMF N,N-dimethylformamide,
  • dppf 1,1′-bis(diphenylphosphino)ferrocene,
  • dppp 1,3-bis(diphenylphosphino)propane,
  • LDA lithium diisopropylamide,
  • MBT MBT ether, methyl tert-butyl ether and
  • THF tetrahydrofuran.


In the present application and in the examples below, the structures of the liquid-crystal compounds are indicated by means of acronyms, the transformation into chemical formulae taking place in accordance with Tables A and B below. All radicals CnH2n+1 and CmH2m+1 are straight-chain alkyl radicals having n and m carbon atoms respectively. The coding in Table B is self-evident. In Table A, only the acronym for the parent structure is indicated. In individual cases, the acronym for the parent structure is followed, separated by a hyphen, by a code for the substituents R1, R2, L1, L2 and L3:

Code for R1, R2, L1, L2, L3R1R2L1L2L3nmCnH2n+1CmH2m+1HHHnOmCnH2n+1OCmH2m+1HHHnO.mOCnH2n+1CmH2m+1HHHnmFFCnH2n+1CmH2m+1FHFnOmFFCnH2n+1OCmH2m+1FHFnO.mFFOCnH2n+1CmH2m+1FHFnO.OmFFOCnH2n+1OCmH2m+1FHFnCnH2n+1CNHHHnN.FCnH2n+1CNFHHnN.F.FCnH2n+1CNFFHnFCnH2n+1FHHHnF.FCnH2n+1FFHHnF.F.FCnH2n+1FFFHnClCnH2n+1ClHHHnCl.FCnH2n+1ClFHHnCl.F.FCnH2n+1ClFFHnmFCnH2n+1CmH2m+1FHHnCF3CnH2n+1CF3HHHnOCF3CnH2n+1OCF3HHHnOCF3.FCnH2n+1OCF3FHHnOCF3.F.FCnH2n+1OCF3FFHnOCF2CnH2n+1OCHF2HHHnOCF2.F.FCnH2n+1OCHF2FFHnSCnH2n+1NCSHHHrVsNCrH2r+1—CH═CH—CsH2sCNHHHnEsNCrH2r+1—O—CsH2sCNHHHnAmCnH2n+1COOCmH2m+1HHHnF.ClCnH2n+1FClHH









TABLE A















embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image


















TABLE B















embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image
















EXAMPLES

The following examples are intended to explain the invention without limiting it. Above and below, percentages are per cent by weight. All temperatures are indicated in degrees Celsius. An denotes the optical anisotropy (589 nm, 20° C.), Δε the dielectric anisotropy (1 kHz, 20° C.), H.R. the voltage holding ratio (at 100° C., after 5 minutes in the oven, 1 V). V10, V50 and V90 (the threshold voltage, mid-grey voltage and saturation voltage respectively) and V0 (the capacitive threshold voltage) were each determined at 20° C.


Substance Examples
Example 1
(4,7-Difluoro-8-methyl-3-pentyl-6H-benzo[c]chromen-6-one)
1.1 Preparation of 4-bromo-2-fluoro-1-pentylbenzene



embedded image


190 g (0.600 mol) of 4-bromo-2-fluoro-1-iodobenzene and 65.3 ml of 1-pentyne were dissolved in a mixture of 900 ml of THF and 1.2 l of triethylamine and cooled to 10° C., and 1.14 g (6 mmol) of copper(I) iodide and 8.42 g (12 mmol) of bis(triphenylphosphine)palladium(II) chloride were added. The batch was stirred overnight at room temperature, water and MTB ether were subsequently added, and the mixture was stirred for a further 5 minutes. The reaction mixture was filtered through Celite® with suction, and the phases were separated. The aqueous phase was extracted twice with MTB ether, and the combined organic phases were washed three times with water, dried over sodium sulfate and evaporated under reduced pressure. The crude product was filtered through silica gel with n-heptane, giving 129 g of 4-bromo-2-fluoro-1-pent-1-ynylbenzene as a yellow liquid. Hydrogenation on palladium/activated carbon (10%) in THF gave 131 g (100%) of 4-bromo-2-fluoro-1-pentylbenzene as a yellow liquid.


1.2 Preparation of 6-bromo-2-fluoro-3-pentylphenol



embedded image


132 g (0.583 mol) of 4-bromo-2-fluoro-1-pentylbenzene were dissolved in 900 ml of THF, and 295 ml of a 2 molar solution of LDA in THF were added dropwise at −70° C. After 1 hour, 65.9 ml (0.590 mol) of trimethyl borate were added, and the mixture was stirred for a further 1 hour and then acidified at −15° C. using 150 ml of 50 per cent acetic acid. The batch was subsequently warmed to 30° C., and 139 ml (1.61 mol) of 35 per cent hydrogen peroxide solution were added dropwise. After 1 hour, the mixture was diluted with water, and the organic phase was separated off. The combined organic phases were washed twice with ammonium iron(II) sulfate solution and once with water, dried over sodium sulfate and evaporated under reduced pressure.


Filtration of the crude product through silica gel with n-heptane/1-chlorobutane (3:1) gave 86.0 g (61% of theory) of 6-bromo-2-fluoro-3-pentylphenol as colourless crystals.


1.3 Preparation of 6-bromo-2-fluoro-3-methylbenzoic acid



embedded image


50 ml (0.385 mol) of 4-bromo-2-fluorotoluene were dissolved in 750 ml of THF, and 231 ml (0.462 mol) of a 2 M solution of LDA in THF were added dropwise at −70° C. After 70 minutes, 37.2 g (0.846 mol) of carbon dioxide were passed in, and the batch was allowed to thaw. After acidification using conc. hydrochloric acid, the solution was extracted with MTB ether, and the combined organic phases were washed with water, dried over sodium sulfate and evaporated under reduced pressure. Crystallisation of the crude product from 1-chlorobutane gave 44.1 g (49%) of 6-bromo-2-fluoro-3-methylbenzoic acid as white crystals.


1.4 Preparation of 6-bromo-2-fluoro-3-pentylphenyl 6-bromo-2-fluoro-3-methylbenzoate



embedded image


43.2 g (0.165 mol) of 6-bromo-2-fluoro-3-pentylphenol, 40.5 g (0.173 mol) of 6-bromo-2-fluoro-3-methylbenzoic acid and 3.52 g (29 mmol) of 4-(dimethylamino)pyridine were initially introduced in 300 ml of dichloro-methane, and a solution of 35.7 g (0.172 mol) of N,N-dicyclohexyl-carbodiimide in 80 ml of dichloromethane was added. The batch was stirred overnight at room temperature, and 4.16 g (33 mmol) of oxalic acid were subsequently added. After 1 hour, the precipitated solid was filtered off, and the filtrate was evaporated under reduced pressure. The crude product was filtered through silica gel with n-heptane/1-chlorobutane (1:1), giving 72.7 g (91% of theory) of 6-bromo-2-fluoro-3-pentylphenyl 6-bromo-2-fluoro-3-methylbenzoate as a colourless oil.


1.5 Preparation of 4,7-difluoro-8-methyl-3-pentyl-6H-benzo[c]chromen-6-one



embedded image


56.2 g (118 mmol) of 6-bromo-2-fluoro-3-pentylphenyl 6-bromo-2-fluoro-3-methylbenzoate were dissolved in 650 ml of DMF, and the mixture was refluxed for 48 hours in the presence of 75.1 g (1.18 mmol) of copper powder. The mixture was subsequently diluted with water and extracted with ethyl acetate. The extracts were combined, dried over Na2SO4 and evaporated. The crude product was recrystallised from 1-chlorobutane, giving 9.60 g of the lactone as a colourless solid. This corresponds to a yield of 26%.


The physical properties of the compound are shown in the following table.


Examples 2 to 120

The following are prepared analogously to Example 1:

embedded imagePhasesequenceT*(N,I)/No.R1R2T/° C.Δε*° C.2CH3CH3C 237 I 3CH3C2H5 4CH3n-C3H7 5CH3n-C4H9 1CH3n-C5H11C 104 I−17.822 6CH3n-C6H13 7CH3n-C7H15 8CH3CH3O 9CH3C2H5O 10CH3n-C3H7O 11CH3n-C4H9O 12CH3CH2═CH 13CH3E-CH3—CH═CH 14CH3CH2═CH—O 15CH3CH2═CH—CH2O 16C2H5CH3 17C2H5C2H5 18C2H5n-C3H7 19C2H5n-C4H9 20C2H5n-C5H11 21C2H5n-C6H13 22C2H5n-C7H17 23C2H5CH3O 24C2H5C2H5O 25C2H5n-C3H7O 26C2H5n-C4H9O 27C2H5CH2═CH 28C2H5E-CH3—CH═CH 29C2H5CH2═CH—O 30C2H5CH2═CH—CH2O 31n-C3H7CH3 32n-C3H7C2H5 33n-C3H7n-C3H7 34n-C3H7n-C4H9 35n-C3H7n-C5H11C 103 I−19.07 36n-C3H7n-C6H13 37n-C3H7n-C7H15 38n-C3H7CH3O 39n-C3H7C2H5O 40n-C3H7n-C3H7O 41n-C3H7n-C4H9O 42n-C3H7CH2═CH 43n-C3H7E-CH3—CH═CH 44n-C3H7CH2═CH—O 45n-C3H7CH2═CH—CH2O 46n-C4H9CH3 47n-C4H9C2H5 48n-C4H9n-C3H7 49n-C4H9n-C4H9 50n-C4H9n-C5H11 51n-C4H9n-C6H13 52n-C4H9n-C7H15 53n-C4H9CH3O 54n-C4H9C2H5O 55n-C4H9n-C3H7O 56n-C4H9n-C4H9O 57n-C4H9CH2═CH 58n-C4H9E-CH3—CH═CH 59n-C4H9CH2═CH—O 60an-C4H9CH2═CH—CH2O 60bn-C5H11n-C4H9OC 130 I−23.557 61CH3OCH3 62CH3OC2H5 63CH3On-C3H7 64CH3On-C4H9 65CH3On-C5H11 66CH3On-C6H13 67CH3On-C7H15 68CH3OCH3O 69CH3OC2H5O 70CH3On-C3H7O 71CH3On-C4H9O 72CH3OCH2═CH 73CH3OE-CH3—CH═CH 74CH3OCH2═CH—O 75CH3OCH2═CH—CH2O 76C2H5OCH3 77C2H5OC2H5 78C2H5On-C3H7 79C2H5On-C4H9 80C2H5On-C5H11C 137 I 81C2H5On-C6H13 82C2H5On-C7H15 83C2H5OCH3O 84C2H5OC2H5O 85C2H5On-C3H7O 86C2H5On-C4H9O 87C2H5OCH2═CH 88C2H5OE-CH3—CH═CH 89C2H5OCH2═CH—O 90C2H5OCH2═CH—CH2O 91CH2═CHCH3 92CH2═CHC2H5 93CH2═CHn-C3H7 94CH2═CHn-C4H9 95CH2═CHn-C5H11 96CH2═CHn-C6H13 97CH2═CHn-C7H15 98CH2═CHCH3O 99CH2═CHC2H5O100CH2═CHn-C3H7O101CH2═CHn-C4H9O102CH2═CHCH2═CH103CH2═CHE-CH3—CH═CH104CH2═CHCH2═CH—O105CH2═CHCH2═CH—CH2O106CH2═CH—OCH3107CH2═CH—OC2H5108CH2═CH—On-C3H7109CH2═CH—On-C4H9110CH2═CH—On-C5H11111CH2═CH—On-C6H13112CH2═CH—On-C7H15113CH2═CH—OCH3O114CH2═CH—OC2H5O115CH2═CH—On-C3H7O116CH2═CH—On-C4H9O117CH2═CH—OCH2═CH118CH2═CH—OE-CH3—CH═CH119CH2═CH—OCH2═CH—O120CH2═CH—OCH2═CH—CH2O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Example 121
(4,7-Difluoro-8-methyl-3-pentyl-6H-benzo[c]chromene)
Preparation of 4,7-difluoro-8-methyl-3-pentyl-6H-benzo[c]chromene



embedded image


2.00 g (6.33 mmol) of the compound from Example 1 were dissolved in 12 ml of THF. 2.56 ml (23 mmol) of boron trifluoride/THF complex were added to this solution with ice-cooling. 12 ml of diethylene glycol dimethyl ether and, in portions, 0.58 g (15 mmol) of sodium borohydride were then added successively, and the mixture was stirred at room temperature (about 20° C.) for 16 hours. The reaction solution was hydrolysed using ice-water and extracted with MTB ether, and the extracts were combined and dried over Na2SO4 and evaporated. The crude product was recrystallised from n-heptane, giving 1.60 g of colourless crystals of the benzochromene. This corresponds to a yield of 83%.


Examples 122 to 240
The following are prepared analogously to Example 121:



















embedded image




















Phase







sequence

T*(N,I)/


No.
R1
R2
T/° C.
Δε*
° C.















122
CH3
CH3
C 110 I
−3.2
27


123
CH3
C2H5


124
CH3
n-C3H7


125
CH3
n-C4H9


121
CH3
n-C5H11
Tg −60 C
−3.1
6





42 I


126
CH3
n-C6H13


127
CH3
n-C7H15


128
CH3
CH3O


129
CH3
C2H5O


130
CH3
n-C3H7O


131
CH3
n-C4H9O


132
CH3
CH2═CH


133
CH3
E-CH3—CH═CH


134
CH3
CH2═CH—O


135
CH3
CH2═CH—CH2O


136
C2H5
CH3


137
C2H5
C2H5


138
C2H5
n-C3H7


139
C2H5
n-C4H9


140
C2H5
n-C5H11


141
C2H5
n-C6H13


142
C2H5
n-C7H15


143
C2H5
CH3O


144
C2H5
C2H5O


145
C2H5
n-C3H7O


146
C2H5
n-C4H9O


147
C2H5
CH2═CH


148
C2H5
E-CH3—CH═CH


149
C2H5
CH2═CH—O


150
C2H5
CH2═CH—CH2O


151
n-C3H7
CH3


152
n-C3H7
C2H5


153
n-C3H7
n-C3H7


154
n-C3H7
n-C4H9


155
n-C3H7
n-C5H11
C 34 I
−2.7


156
n-C3H7
n-C6H13


157
n-C3H7
n-C7H15


158
n-C3H7
CH3O


159
n-C3H7
C2H5O


160
n-C3H7
n-C3H7O


161
n-C3H7
n-C4H9O


162
n-C3H7
CH2═CH


163
n-C3H7
E-CH3—CH═CH


164
n-C3H7
CH2═CH—O


165
n-C3H7
CH2═CH—CH2O


166
n-C4H9
CH3


167
n-C4H9
C2H5


168
n-C4H9
n-C3H7


169
n-C4H9
n-C4H9


170
n-C4H9
n-C5H11


171
n-C4H9
n-C6H13


172
n-C4H9
n-C7H15


173
n-C4H9
CH3O


174
n-C4H9
C2H5O


175
n-C4H9
n-C3H7O


176
n-C4H9
n-C4H9O


177
n-C4H9
CH2═CH


178
n-C4H9
E-CH3—CH═CH


179
n-C4H9
CH2═CH—O


180a
n-C4H9
CH2═CH—CH2O


180b
n-C5H11
n-C4H9O


181
CH3O
CH3


182
CH3O
C2H5


183
CH3O
n-C3H7


184
CH3O
n-C4H9


185
CH3O
n-C5H11


186
CH3O
n-C6H13


187
CH3O
n-C7H15


188
CH3O
CH3O


189
CH3O
C2H5O


190
CH3O
n-C3H7O


191
CH3O
n-C4H9O


192
CH3O
CH2═CH


193
CH3O
E-CH3—CH═CH


194
CH3O
CH2═CH—O


195
CH3O
CH2═CH—CH2O


196
C2H5O
CH3


197
C2H5O
C2H5


198
C2H5O
n-C3H7


199
C2H5O
n-C4H9


200
C2H5O
n-C5H11
Tg −39 C
−6.5
39





55 N





(17.4) I


201
C2H5O
n-C6H13


202
C2H5O
n-C7H15


203
C2H5O
CH3O


204
C2H5O
C2H5O


205
C2H5O
n-C3H7O


206
C2H5O
n-C4H9O


207
C2H5O
CH2═CH


208
C2H5O
E-CH3—CH═CH


209
C2H5O
CH2═CH—O


210a
C2H5O
CH2═CH—CH2O


210b
n-C4H9O
n-C5H11


211
CH2═CH
CH3


212
CH2═CH
C2H5


213
CH2═CH
n-C3H7


214
CH2═CH
n-C4H9


215
CH2═CH
n-C5H11


216
CH2═CH
n-C6H13


217
CH2═CH
n-C7H15


218
CH2═CH
CH3O


219
CH2═CH
C2H5O


220
CH2═CH
n-C3H7O


221
CH2═CH
n-C4H9O


222
CH2═CH
CH2═CH


223
CH2═CH
E-CH3—CH═CH


224
CH2═CH
CH2═CH—O


225
CH2═CH
CH2═CH—CH2O


226
CH2═CH—O
CH3


227
CH2═CH—O
C2H5


228
CH2═CH—O
n-C3H7


229
CH2═CH—O
n-C4H9


230
CH2═CH—O
n-C5H11


231
CH2═CH—O
n-C6H13


232
CH2═CH—O
n-C7H15


233
CH2═CH—O
CH3O


234
CH2═CH—O
C2H5O


235
CH2═CH—O
n-C3H7O


236
CH2═CH—O
n-C4H9O


237
CH2═CH—O
CH2═CH


238
CH2═CH—O
E-CH3—CH═CH


239
CH2═CH—O
CH2═CH—O


240
CH2═CH—O
CH2═CH—CH2O







Note





*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).







Example 241
(8-Ethoxy-4,6,6,7-tetrafluoro-3-pentyl-6H-benzo[c]-chromene)
Preparation of 8-ethoxy-4,6,6,7-tetrafluoro-3-pentyl-6H-benzo[c]chromene



embedded image


4.00 g (11.5 mmol) of the compound from Example 80 and 5.14 g (12.7 mmol) of Lawesson's reagent were dissolved in 60 ml of chlorobenzene, and the mixture was refluxed for 48 hours. The batch was subsequently evaporated and subjected to conventional purification, giving 2.90 g (8.00 mmol) of the corresponding thionolactone as an orange solid. This corresponds to a yield of 69%.


The thionolactone was dissolved in 40 ml of dichloromethane. 2.1 ml (16.1 mmol) of DAST were then added, and the mixture was stirred at about 20° C. for 16 hours and subjected to conventional purification. The crude product was purified via silica gel with a mixture of n-heptane/ethyl acetate (9:1) and recrystallised from ethanol, giving 0.46 9 of the difluorobenzochromene. This corresponds to a yield of 15%.


Examples 242 to 360

The following are prepared analogously to Example 241:

embedded imagePhase sequenceNo.R1R2T/° C.Δε*242CH3CH3243CH3C2H5244CH3n-C3H7245CH3n-C4H9246CH3n-C5H11247CH3n-C6H13248CH3n-C7H15249CH3CH3O250CH3C2H5O251CH3n-C3H7O252CH3n-C4H9O253CH3CH2═CH254CH3E-CH3—CH═CH255CH3CH2═CH—O256CH3CH2═CH—CH2O257C2H5CH3258C2H5C2H5259C2H5n-C3H7260C2H5n-C4H9261C2H5n-C5H11262C2H5n-C6H13263C2H5n-C7H15264C2H5CH3O265C2H5C2H5O266C2H5n-C3H7O267C2H5n-C4H9O268C2H5CH2═CH269C2H5E-CH3—CH═CH270C2H5CH2═CH—O271C2H5CH2═CH—CH2O272n-C3H7CH3273n-C3H7C2H5274n-C3H7n-C3H7275n-C3H7n-C4H9276n-C3H7n-C5H11C 53 I−10.4277n-C3H7n-C6H13278n-C3H7n-C7H15279n-C3H7CH3O280n-C3H7C2H5O281n-C3H7n-C3H7O282n-C3H7n-C4H9O283n-C3H7CH2═CH284n-C3H7E-CH3—CH═CH285n-C3H7CH2═CH—O286n-C3H7CH2═CH—CH2O287n-C4H9CH3288n-C4H9C2H5289n-C4H9n-C3H7290n-C4H9n-C4H9291n-C4H9n-C5H11292n-C4H9n-C6H13293n-C4H9n-C7H15294n-C4H9CH3O295n-C4H9C2H5O296n-C4H9n-C3H7O297n-C4H9n-C4H9O298n-C4H9CH2═CH299n-C4H9E-CH3—CH═CH300n-C4H9CH2═CH—O301an-C4H9CH2═CH—CH2O301bn-C5H11n-C4H9O302CH3OCH3303CH3OC2H5304CH3On-C3H7305CH3On-C4H9306CH3On-C5H11307CH3On-C6H13308CH3On-C7H15309CH3OCH3O310CH3OC2H5O311CH3On-C3H7O312CH3On-C4H9O313CH3OCH2═CH314CH3OE-CH3—CH═CH315CH3OCH2═CH—O316CH3OCH2═CH—CH2O317C2H5OCH3318C2H5OC2H5319C2H5On-C3H7320C2H5On-C4H9241C2H5On-C5H11C 85 I−15.4321C2H5On-C6H13322C2H5On-C7H15323C2H5OCH3O324C2H5OC2H5O325C2H5On-C3H7O326C2H5On-C4H9O327C2H5OCH2═CH328C2H5OE-CH3—CH═CH329C2H5OCH2═CH—O330aC2H5OCH2═CH—CH2O330bn-C4H9On-C5H11331CH2═CHCH3332CH2═CHC2H5333CH2═CHn-C3H7334CH2═CHn-C4H9335CH2═CHn-C5H11336CH2═CHn-C6H13337CH2═CHn-C7H15338CH2═CHCH3O339CH2═CHC2H5O340CH2═CHn-C3H7O341CH2═CHn-C4H9O342CH2═CHCH2═CH343CH2═CHE-CH3—CH═CH344CH2═CHCH2═CH—O345CH2═CHCH2═CH—CH2O346CH2═CH—OCH3347CH2═CH—OC2H5348CH2═CH—On-C3H7349CH2═CH—On-C4H9350CH2═CH—On-C5H11351CH2═CH—On-C6H13352CH2═CH—On-C7H15353CH2═CH—OCH3O354CH2═CH—OC2H5O355CH2═CH—On-C3H7O356CH2═CH—On-C4H9O357CH2═CH—OCH2═CH358CH2═CH—OE-CH3—CH═CH359CH2═CH—OCH2═CH—O360CH2═CH—OCH2═CH—CH2O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Example 361a
(3-Butoxy-4,6,6,7-tetrafluoro-8-(4-pentylcyclohexyl)-6H-benzo[c]chromene)
361.1 Preparation of 4-bromo-2-fluoro-1-(4-pentylcyclohex-1 -enyl)benzene



embedded image


200 g (0.665 mol) of 1-bromo-3-fluoro-4-iodobenzene were dissolved in 800 ml of tetrahydrofuran, and 440 ml (0.698 mmol) of a 15 per cent solution of n-butyllithium in hexane were added dropwise at −70° C. After 30 minutes, a solution of 117 g (0.698 mol) of 4-pentylcyclohexanone in 200 ml of tetrahydrofuran was added, and the batch was left to stirr for 60 minutes, hydrolysed using water and acidified using conc. hydrochloric acid. The organic phase was separated off, washed with water and dried over sodium sulfate, and the solvent was removed under reduced pressure. The crude product was subsequently dissolved in 1.4 l of toluene and, after addition of 6 g of toluenesulfonic acid, heated on a water separator until water of reaction was no longer separated off. The solution was washed with water and evaporated, and the residue was filtered through silica gel with n-heptane, giving 124 g (58%) of 4-bromo-2-fluoro-1-(4-pentylcyclohex-1-enyl)benzene as a yellow oil.


361.2 Preparation of 4-bromo-2-fluoro-1-(4-pentylcyclohexyl)benzene



embedded image


124 g (0.382 mol) of 4-bromo-2-fluoro-1-(4-pentylcyclohex-1-enyl)benzene were hydrogenated to completion at 5 bar and 50° C. in tetrahydrofuran on platinum/activated carbon catalyst. Filtration and removal of the solvent under reduced pressure gave 114 g (80%) of a mixture of cis- and trans-4-bromo-2-fluoro-1-(4-pentylcyclohexyl)benzene as a yellow oil. For isomerisation, this was dissolved in 200 ml of dichloromethane and added dropwise to a suspension of 12.5 g (95.7 mmol) of aluminium chloride in 220 ml of dichloromethane. After 30 minutes, 300 ml of water were added, and the organic phase was separated off, washed with water and dried over sodium sulfate. The solvent was removed under reduced pressure, and the residue was filtered through silica gel with n-pentane, giving 85.2 g of crude product having a content of trans-4-bromo-2-fluoro-1-(4-pentyl-cyclohexyl)benzene of 52.8% and a content of cis-4-bromo-2-fluoro-1-(4-pentylcyclohexyl)benzene of 9.7% as a yellow liquid, which was employed in the next step without further purification.


361.3 Preparation of trans-6-bromo-2-fluoro-3-(4-pentylcyclohexyl)benzoic acid



embedded image


85.2 g (0.163 mol) of the crude product from the preceding step were initially introduced in 400 ml of tetrahydrofuran at −70° C., and a solution of lithium diisopropylamide, prepared from 213 ml of 15 per cent n-butyllithium in hexane and 46 ml (0.326 mmol) of diisopropylamine in 100 ml of tetrahydrofuran, was added dropwise. After 1 hour, 22.9 g (0.521 mol) of carbon dioxide were passed in. The batch was allowed to thaw, acidified using conc. hydrochloric acid and extracted twice with MTB ether. The combined organic phases were washed with water and dried over sodium sulfate, and the solvent was removed under reduced pressure. Crystallisation from n-heptane gave 17 g (28%) of trans-6-bromo-2-fluoro-3-(4-pentylcyclohexyl)benzoic acid as colourless crystals.


361.4 Preparation of methyl trans-6-bromo-2-fluoro-3-(4-pentylcyclohexyl)-benzoate



embedded image


17.1 g (46.0 mmol) of trans-6-bromo-2-fluoro-3-(4-pentylcyclohexyl)-benzoic acid were dissolved in 70 ml of acetone, 7.66 g (55.4 mmol) of potassium carbonate and 3.14 ml (50.6 mmol) of methyl iodide were added, and the mixture was refluxed overnight. The batch was filtered, and the solvent was distilled off, giving 18 g (100%) of methyl 6-bromo-2-fluoro-3-(4-pentylcyclohexyl)benzoate as a colourless oil, which was reacted further without further purification.


361.5 Preparation of 1-bromo-4-butoxy-3-fluoro-2-(2-methoxyethoxy-methoxy)benzene



embedded image


Analogously to Examples 841.1 and 841.4, 4-bromo-2-fluorophenol gave 6-bromo-3-butoxy-2-fluorophenol as a brown oil (80%, 2 steps).


60.4 ml (0.355 mol) of ethyldiisopropylamine were added with ice-cooling to 77.4 g (0.294 mol) of 6-bromo-3-butoxy-2-fluorophenol dissolved in 500 ml of dichloromethane, 40.3 ml (0.355 mol) of 2-methoxyethoxymethyl chloride were added dropwise, and the mixture was left to stirr overnight at room temperature. The batch was hydrolysed using water, extracted with dichloromethane and evaporated, and the crude product was filtered through silica gel with n-heptane/MTB ether (3:1), giving 103 g (99%) of 1-bromo-4-butoxy-3-fluoro-2-(2-methoxyethoxymethoxy)benzene as a yellow oil.


361.6 Preparation of 3-butoxy-4,7-difluoro-8-(4-pentylcyclohexyl)-benzo[c]chromen-6-one



embedded image


16.4 g (0.046 mol) of 1-bromo-4-butoxy-3-fluoro-2-(2-methoxyethoxy-methoxy)benzene were dissolved in 20 ml of tetrahydrofuran, and 31.6 ml (0.052 mol) of a 15 per cent solution of n-butyllithium in hexane were added at −70° C. After addition of a solution of 5.94 g (0.027 mol) of zinc bromide in 30 ml of tetrahydrofuran, the batch was allowed to thaw, and the resultant solution was added at the boiling point to a mixture of 18 g (0.046 mol) of methyl 6-bromo-2-fluoro-3-(4-pentylcyclohexyl)benzoate and 730 mg (1.00 mmol) of Pd(dppf)2Cl2 in 60 ml of tetrahydrofuran. The batch was refluxed for 4 hours, stirred overnight at room temperature, acidified using dilute hydrochloric acid and extracted with MTB ether. The combined organic phases were washed with water, dried over sodium sulfate and evaporated. The crude product was chromatographed over silica gel with n-pentane/MTB ether (3:1), giving 14.6 g (55%) of methyl 4′-butoxy-3,3′-difluoro-2′-(2-methoxyethoxymethoxy)-4-(4-pentylcyclohexyl)-biphenyl-2-carboxylate as a yellow oil. This was dissolved in 56 ml of tetrahydrofuran, 11 ml of conc. hydrochloric acid were added, and the mixture was stirred overnight at room temperature. The precipitated product was filtered off with suction, washed with ethyl acetate and dried, giving 7.6 g (68%) of 3-butoxy-4,7-difluoro-8-(4-pentylcyclohexyl)-benzo[c]chromen-6-one as colourless crystals.


361.7 Preparation of 3-butoxy-4,7-difluoro-8-(4-pentylcyclohexyl)-benzo[c]chromene-6-thione



embedded image


11.7 g (25.6 mmol) of 3-butoxy-4,7-difluoro-8-(4-pentylcyclohexyl)-benzo[c]chromen-6-one and 11.4 g (28.2 mmol) of Lawesson's reagent were refluxed for 16 hours in 130 ml of chlorobenzene. The solution was subsequently filtered through silica gel and evaporated, and the crude product was purified by crystallisation from MTB ether, giving 7.9 g (65%) of 3-butoxy-4,7-difluoro-8-(4-pentylcyclohexyl)benzo[c]chromene-6-thione as yellow crystals.


361.8 Preparation of 3-butoxy-4,6,6,7-tetrafluoro-8-(4-pentylcyclohexyl)-6H-benzo[c]chromene



embedded image


2.00 g (4.18 mmol) of 3-butoxy-4,7-difluoro-8-(4-pentylcyclohexyl)benzo-[c]chromene-6-thione were dissolved in 20 ml of dichloromethane and cooled to −70° C., 0.55 ml (20 mmol) of a 65 percent solution of hydrogen fluoride in pyridine was added, and a suspension of 2.56 g (8.36 mmol) of 1,3-dibromo-5,5-dimethylhydantoin in 12 ml of dichloromethane was added in portions. After 2 hours, the batch was allowed to thaw, and was neutralised using sat. sodium hydrogencarbonate solution and extracted with dichloromethane. The organic phases were washed with water, dried over sodium sulfate and evaporated, and the crude product was chromatographed over silica gel with heptane/toluene (1:2). Crystallisation from n-heptane gave 1.0 g (52%) of 3-butoxy-4,6,6,7-tetrafluoro-8-(4-pentylcyclohexyl)-6H-benzo[c]chromene as colourless crystals of melting point 99° C.


The compound exhibited the following phase behaviour: C 99° C. N 130.5° C. I and has an extrapolated clearing point of 148° C., and at 20° C. an extrapolated birefringence of 0.153 and an extrapolated dielectric anisotropy of −16.7.


Examples 361b and 362 to 390

The following are prepared analogously to Example 241 and Example 361 a:

embedded imagePhase sequenceT*(N,I)/No.R1R2T/° C.Δε*° C.361bCH3CH3362CH3C2H5363CH3n-C3H7364C2H5CH3365C2H5C2H5366C2H5n-C3H7367n-C3H7CH3368n-C3H7C2H5369n-C3H7n-C3H7370n-C3H7n-C5H11371n-C5H11n-C3H7372n-C5H11n-C5H11373CH2═CHCH3374CH2═CHC2H5375CH2═CHn-C3H7376CH2═CHCH2═CH377CH3CH2═CH378C2H5CH2═CH379n-C3H7CH2═CH380E-CH3—CH═CHCH2═CH381E-CH3—CH═CHE-CH3—CH═CH382CH3CH3O383CH3C2H5O384CH3n-C3H7O385n-C3H7CH3O386n-C3H7C2H5O387n-C3H7n-C3H7O361an-C5H11n-C4H9OC 99 N 130.5 I−16.7148388an-C4H9On-C5H11388bCH3OCH3O389C2H5OC2H5O390n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Examples 391 to 420

The following are prepared analogously to Example 241 and Example 361 a:

embedded imagePhase sequenceNo.R1R2T/° C.Δε*391CH3CH3392CH3C2H5393CH3n-C3H7394C2H5CH3395C2H5C2H5396C2H5n-C3H7397n-C3H7CH3398n-C3H7C2H5399n-C3H7n-C3H7400n-C3H7n-C5H11401n-C5H11n-C3H7402n-C5H11n-C5H11403CH2═CHCH3404CH2═CHC2H5405CH2═CHn-C3H7406CH2═CHCH2═CH407CH3CH2═CH408C2H5CH2═CH409n-C3H7CH2═CH410E-CH3—CH═CHCH2═CH411E-CH3—CH═CHE-CH3—CH═CH412CH3CH3O413CH3C2H5O414CH3n-C3H7O415n-C3H7CH3O416n-C3H7C2H5O417an-C3H7n-C3H7O417bn-C5H11n-C4H9O417cn-C4H9On-C5H11418CH3OCH3O419C2H5OC2H5O420n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Examples 421 to 450

The following are prepared analogously to Example 241 and Example 361a:

embedded imagePhase sequenceNo.R1R2T/° C.Δε*421CH3CH3422CH3C2H5423CH3n-C3H7424C2H5CH3425C2H5C2H5426C2H5n-C3H7427n-C3H7CH3428n-C3H7C2H5429n-C3H7n-C3H7430n-C3H7n-C5H11431n-C5H11n-C3H7432n-C5H11n-C5H11453CH2═CHCH3434CH2═CHC2H5435CH2═CHn-C3H7436CH2═CHCH2═CH437CH3CH2═CH438C2H5CH2═CH439n-C3H7CH2═CH440E-CH3—CH═CHCH2═CH441E-CH3—CH═CHE-CH3—CH═CH442CH3CH3O443CH3C2H5O444CH3n-C3H7O445n-C3H7CH3O446n-C3H7C2H5O447an-C3H7n-C3H7O447bn-C5H11n-C4H9O447cn-C4H9On-C5H11448CH3OCH3O449C2H5OC2H5O450n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792.


Examples 451 to 480

The following are prepared analogously to Example 241 and Example 361 a:

embedded imagePhase sequenceNo.R1R2T/° C.Δε*451CH3CH3452CH3C2H5453CH3n-C3H7454C2H5CH3455C2H5C2H5456C2H5n-C3H7457n-C3H7CH3458n-C3H7C2H5459n-C3H7n-C3H7460n-C3H7n-C5H11461n-C5H11n-C3H7462n-C5H11n-C5H11463CH2═CHCH3464CH2═CHC2H5465CH2═CHn-C3H7466CH2═CHCH2═CH467CH3CH2═CH468C2H5CH2═CH469n-C3H7CH2═CH470E-CH3—CH═CHCH2═CH471E-CH3—CH═CHE-CH3—CH═CH472CH3CH3O473CH3C2H5O474CH3n-C3H7O475n-C3H7CH3O476n-C3H7C2H5O477an-C3H7n-C3H7O477bn-C5H11n-C4H9O477cn-C4H9On-C5H11478CH3OCH3O479C2H5OC2H5O480n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Examples 481 to 510

The following are prepared analogously to Example 241 and Example 361a:

embedded imagePhase sequenceNo.R1R2T/° C.Δε*481CH3CH3482CH3C2H5483CH3n-C3H7484C2H5CH3485C2H5C2H5486C2H5n-C3H7487n-C3H7CH3488n-C3H7C2H5489n-C3H7n-C3H7490n-C3H7n-C5H11491n-C5H11n-C3H7492n-C5H11n-C5H11493CH2═CHCH3494CH2═CHC2H5495CH2═CHn-C3H7496CH2═CHCH2═CH497CH3CH2═CH498C2H5CH2═CH499n-C3H7CH2═CH500E-CH3—CH═CHCH2═CH501E-CH3—CH═CHE-CH3—CH═CH502CH3CH3O503CH3C2H5O504CH3n-C3H7O505n-C3H7CH3O506n-C3H7C2H5O507an-C3H7n-C3H7O507bn-C5H11n-C4H9O507cn-C4H9On-C5H11508CH3OCH3O509C2H5OC2H5O510n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Examples 511 to 540

The following are prepared analogously to Example 241 and Example 361a:

embedded imagePhase sequenceNo.R1R2T/° C.Δε*511CH3CH3512CH3C2H5513CH3n-C3H7514C2H5CH3515C2H5C2H5516C2H5n-C3H7517n-C3H7CH3518n-C3H7C2H5519n-C3H7n-C3H7520n-C3H7n-C5H11521n-C5H11n-C3H7522n-C5H11n-C5H11523CH2═CHCH3524CH2═CHC2H5525CH2═CHn-C3H7526CH2═CHCH2═CH527CH3CH2═CH528C2H5CH2═CH529n-C3H7CH2═CH530E-CH3—CH═CHCH2═CH531E-CH3—CH═CHE-CH3—CH═CH532CH3CH3O533CH3C2H5O534CH3n-C3H7O535n-C3H7CH3O536n-C3H7C2H5O537an-C3H7n-C3H7O537bn-C5H11n-C4H9O537cn-C4H9On-C5H11538CH3OCH3O539C2H5OC2H5O540n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Examples 541 to 570

The following are prepared analogously to Example 241 and Example 361 a:

embedded imagePhase sequenceNo.R1R2T/° C.Δε*541CH3CH3542CH3C2H5543CH3n-C3H7544C2H5CH3545C2H5C2H5546C2H5n-C3H7547n-C3H7CH3548n-C3H7C2H5549n-C3H7n-C3H7550n-C3H7n-C5H11551n-C5H11n-C3H7552n-C5H11n-C5H11553CH2═CHCH3554CH2═CHC2H5555CH2═CHn-C3H7556CH2═CHCH2═CH557CH3CH2═CH558C2H5CH2═CH559n-C3H7CH2═CH560E-CH3—CH═CHCH2═CH561E-CH3—CH═CHE-CH3—CH═CH562CH3CH3O563CH3C2H5O564CH3n-C3H7O565n-C3H7CH3O566n-C3H7C2H5O567an-C3H7n-C3H7O567bn-C5H11n-C4H9O567cn-C4H9On-C5H11568CH3OCH3O569C2H5OC2H5O570n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Examples 571 to 600

The following are prepared analogously to Example 241 and Example 361 a:

embedded imagePhase sequenceNo.R1R2T/° C.Δε*571CH3CH3572CH3C2H5573CH3n-C3H7574C2H5CH3575C2H5C2H5576C2H5n-C3H7577n-C3H7CH3578n-C3H7C2H5579n-C3H7n-C3H7580n-C3H7n-C5H11581n-C5H11n-C3H7582n-C5H11n-C5H11583CH2═CHCH3584CH2═CHC2H5585CH2═CHn-C3H7586CH2═CHCH2═CH587CH3CH2═CH588C2H5CH2═CH589n-C3H7CH2═CH590E-CH3—CH═CHCH2═CH591E-CH3—CH═CHE-CH3—CH═CH592CH3CH3O593CH3C2H5O594CH3n-C3H7O595n-C3H7CH3O596n-C3H7C2H5O597an-C3H7n-C3H7O597bn-C5H11n-C4H9O597cn-C4H9On-C5H11598CH3OCH3O599C2H5OC2H5O600n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Examples 601 to 630

The following are prepared analogously to Example 241 and Example 361a:

embedded imagePhase sequenceNo.R1R2T/° C.Δε*601CH3CH3602CH3C2H5603CH3n-C3H7604C2H5CH3605C2H5C2H5606C2H5n-C3H7607n-C3H7CH3608n-C3H7C2H5609n-C3H7n-C3H7610n-C3H7n-C5H11611n-C5H11n-C3H7612n-C5H11n-C5H11613CH2═CHCH3614CH2═CHC2H5615CH2═CHn-C3H7616CH2═CHCH2═CH617CH3CH2═CH618C2H5CH2═CH619n-C3H7CH2═CH620E-CH3—CH═CHCH2═CH621E-CH3—CH═CHE-CH3—CH═CH622CH3CH3O623CH3C2H5O624CH3n-C3H7O625n-C3H7CH3O626n-C3H7C2H5O627an-C3H7n-C3H7O627bn-C5H11n-C4H9O527cn-C4H9On-C5H11628CH3OCH3O629C2H5OC2H5O630n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Examples 631 to 660

The following are prepared analogously to Example 241 and Example 361 a:

embedded imagePhasesequenceNo.R1R2T/° C.Δε*631CH3CH3632CH3C2H5633CH3n-C3H7634C2H5CH3635C2H5C2H5636C2H5n-C3H7637n-C3H7CH3638n-C3H7C2H5639n-C3H7n-C3H7640n-C3H7n-C5H11641n-C5H11n-C3H7642n-C5H11n-C5H11643CH2═CHCH3644CH2═CHC2H5645CH2═CHn-C3H7646CH2═CHCH2═CH677CH3CH2═CH648C2H5CH2═CH649n-C3H7CH2═CH650E-CH3—CH═CHCH2═CH651E-CH3—CH═CHE-CH3—CH═CH652CH3CH3O653CH3C2H5O654CH3n-C3H7O655n-C3H7CH3O656n-C3H7C2H5O657an-C3H7n-C3H7O657bn-C5H11n-C4H9O5617cn-C4H9On-C5H11658CH3OCH3O659C2H5OC2H5O660n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Examples 661 to 690

The following are prepared analogously to Example 241 and Example

embedded imagePhase sequenceNo.R1R2T/° C.Δε*661CH3CH3662CH3C2H5663CH3n-C3H7664C2H5CH3665C2H5C2H5666C2H5n-C3H7667n-C3H7CH3668n-C3H7C2H5669n-C3H7n-C3H7670n-C3H7n-C5H11671n-C5H11n-C3H7672n-C5H11n-C5H11673CH2═CHCH3674CH2═CHC2H5675CH2═CHn-C3H7676CH2═CHCH2═CH677CH3CH2═CH678C2H5CH2═CH679n-C3H7CH2═CH680E-CH3—CH═CHCH2═CH681E-CH3—CH═CHE-CH3—CH═CH682CH3CH3O683CH3C2H5O684CH3n-C3H7O685n-C3H7CH3O686n-C3H7C2H5O687an-C3H7n-C3H7O687bn-C5H11n-C4H9O687cn-C4H9On-C5H11688CH3OCH3O689C2H5OC2H5O690n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Examples 691 to 720
The following are prepared analogously to Example 241 and Example 361 a:



















embedded image



















Phase sequence



No.
R1
R2
T/° C.
Δε*





691
CH3
CH3




692
CH3
C2H5


693
CH3
n-C3H7


694
C2H5
CH3


695
C2H5
C2H5


696
C2H5
n-C3H7


697
n-C3H7
CH3


698
n-C3H7
C2H5


699
n-C3H7
n-C3H7


700
n-C3H7
n-C5H11


701
n-C5H11
n-C3H7


702
n-C5H11
n-C5H11


703
CH2═CH
CH3


704
CH2═CH
C2H5


705
CH2═CH
n-C3H7


706
CH2═CH
CH2═CH


707
CH3
CH2═CH


708
C2H5
CH2═CH


709
n-C3H7
CH2═CH


710
E-CH3—CH═CH
CH2═CH


711
E-CH3—CH═CH
E-CH3—CH═CH


712
CH3
CH3O


713
CH3
C2H5O


714
CH3
n-C3H7O


715
n-C3H7
CH3O


716
n-C3H7
C2H5O


717a
n-C3H7
n-C3H7O


717b
n-C5H11
n-C4H9O


717c
n-C4H9O
n-C5H11


718
CH3O
CH3O


719
C2H5O
C2H5O


720
n-C3H7O
n-C3H7O







Note





*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).







Examples 721 to 750

The following are prepared analogously to Example 241 and Example 361a:

embedded imagePhase sequenceNo.R1R2T/° C.Δε*721CH3CH3722CH3C2H5723CH3n-C3H7724C2H5CH3725C2H5C2H5726C2H5n-C3H7727n-C3H7CH3728n-C3H7C2H5729n-C3H7n-C3H7730n-C3H7n-C5H11731n-C5H11n-C3H7732n-C5H11n-C5H11733CH2═CHCH3734CH2═CHC2H5735CH2═CHn-C3H7736CH2═CHCH2═CH737CH3CH2═CH738C2H5CH2═CH739n-C3H7CH2═CH740E-CH3—CH═CHCH2═CH741E-CH3—CH═CHE-CH3—CH═CH742CH3CH3O743CH3C2H5O744CH3n-C3H7O745n-C3H7CH3O746n-C3H7C2H5O747an-C3H7n-C3H7O747bn-C5H11n-C4H9O747cn-C4H9On-C5H11748CH3OCH3O749C2H5OC2H5O750n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Examples 751 to 780

The following are prepared analogously to Example 241 and Example 361 a:

embedded imagePhase sequenceNo.R1R2T/° C.Δε*751CH3CH3752CH3C2H5753CH3n-C3H7754C2H5CH3755C2H5C2H5756C2H5n-C3H7757n-C3H7CH3758n-C3H7C2H5759n-C3H7n-C3H7760n-C3H7n-C5H11761n-C5H11n-C3H7762n-C5H11n-C5H11763CH2═CHCH3764CH2═CHC2H5765CH2═CHn-C3H7766CH2═CHCH2═CH767CH3CH2═CH768C2H5CH2═CH769n-C3H7CH2═CH770E-CH3—CH═CHCH2═CH771E-CH3—CH═CHE-CH3—CH═CH772CH3CH3O773CH3C2H5O774CH3n-C3H7O775n-C3H7CH3O776n-C3H7C2H5O777an-C3H7n-C3H7O777bn-C5H11n-C4H9O777cn-C4H9On-C5H11778CH3OCH3O779C2H5OC2H5O780n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Examples 781 to 810

The following are prepared analogously to Example 241 and Example 361 a:

embedded imagePhase sequenceNo.R1R2T/° C.Δε*781CH3CH3782CH3C2H5783CH3n-C3H7784C2H5CH3785C2H5C2H5786C2H5n-C3H7787n-C3H7CH3788n-C3H7C2H5789n-C3H7n-C3H7790n-C3H7n-C5H11791n-C5H11n-C3H7792n-C5H11n-C5H11793CH2═CHCH3794CH2═CHC2H5795CH2═CHn-C3H7796CH2═CHCH2═CH797CH3CH2═CH798C2H5CH2═CH799n-C3H7CH2═CH800E-CH3—CH═CHCH2═CH801E-CH3—CH═CHE-CH3—CH═CH802CH3CH3O803CH3C2H5O804CH3n-C3H7O805n-C3H7CH3O806n-C3H7C2H5O807an-C3H7n-C3H7O807bn-C5H11n-C4H9O807cn-C4H9On-C5H11808CH3OCH3O809C2H5OC2H5O810n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Examples 811 to 840

The following are prepared analogously to Example 241 and Example 361a:

embedded imagePhase sequenceNo.R1R2T/° C.Δε*811CH3CH3812CH3C2H5813CH3n-C3H7814C2H5CH3815C2H5C2H5816C2H5n-C3H7817n-C3H7CH3818n-C3H7C2H5819n-C3H7n-C3H7820n-C3H7n-C5H11821n-C5H11n-C3H7822n-C5H11n-C5H11823CH2═CHCH3824CH2═CHC2H5825CH2═CHn-C3H7826CH2═CHCH2═CH827CH3CH2═CH828C2H5CH2═CH829n-C3H7CH2═CH830E-CH3—CH═CHCH2═CH831E-CH3—CH═CHE-CH3—CH═CH832CH3CH3O833CH3C2H5O834CH3n-C3H7O835n-C3H7CH3O836n-C3H7C2H5O837an-C3H7n-C3H7O837bn-C5H11n-C4H9O837cn-C4H9On-C5H11838CH3OCH3O839C2H5OC2H5O840n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Example 841
(8-Ethoxy-4,7-difluoro-3-benzyloxybenzo[c]chromen-6-one)
841.1 Preparation of 4-bromo-1-ethoxy-2-fluorobenzene



embedded image


100 g (0.524 mol) of 4-bromo-2-fluorophenol and 66.7 g (0.612 mol) of ethyl bromide were dissolved in 2 1 of ethyl methyl ketone and refluxed for 24 hours in the presence of 185 g (1.34 mol) of potassium carbonate. The solution was subsequently filtered, the filtrate was evaporated, and the crude product was filtered through silica gel with n-hexane, giving 114 g (99% of theory) of 4-bromo-1-ethoxy-2-fluorobenzene as a colourless liquid.


841.2 Preparation of 6-bromo-3-ethoxy-2-fluorobenzoic acid



embedded image


Analogously to the synthesis described above (under Example 1.3), 236 g of 4-bromo-1-ethoxy-2-fluorobenzene gave 190 g (64% of theory) of 6-bromo-3-ethoxy-2-fluorobenzoic acid as colourless crystals.


841.3 Preparation of 1-benzyloxy-4-bromo-2-fluorobenzene



embedded image


Analogously to the synthesis described above (under Example 2.1 or 872.1), 250 g (1.31 mol) of 4-bromo-2-fluorophenol and 179 ml (1.51 mol) of benzyl bromide gave 366 g (97%) of 1-benzyloxy-4-bromo-2-fluorobenzene as colourless crystals.


841.4 Preparation of 3-benzyloxy-6-bromo-2-fluorophenol



embedded image


Analogously to the synthesis described above (under Example 1.2), 366 g (1.27 mol) of 1-benzyloxy-4-bromo-2-fluorobenzene give 270 g (72% of theory) of 3-benzyloxy-6-bromo-2-fluorophenol as colourless crystals.


841.5 Preparation of 3-benzyloxy-6-bromo-2-fluorophenyl 6-bromo-3-ethoxy-2-fluorobenzoate



embedded image


Analogously to the synthesis described above (under Example 1.4), 253 g (0.851 mol) of 3-benzyloxy-6-bromo-2-fluorophenol and 246 g (0.936 mol) of 6-bromo-3-ethoky-2-fluorobenzoic acid give 405 g (87% of theory) of 3-benzyloxy-6-bromo-2-fluorophenyl 6-bromo-3-ethoxy-2-fluorobenzoate as colourless crystals.


841.6 Preparation of 8-ethoxy-4,7-difluoro-3-benzyloxybenzo[c]chromen-6-one



embedded image


103 g (0.188 mol) of 3-benzyloxy-6-bromo-2-fluorophenyl 6-bromo-3-ethoxy-2-fluorobenzoate were dissolved in 1 l of DMF and refluxed for 72 hours in the presence of 119 g (1.88 mol) of copper powder. The batch was subsequently diluted with water and extracted with ethyl acetate, and the combined extracts were dried over sodium sulfate and evaporated. Crystallisation of the crude product from THF gave 15 g (21 % of theory) of 8-ethoxy-4,7-difluoro-3-benzyloxybenzo[c]chromen-6-one as pale-yellow crystals.


Examples 842 to 881

The following are prepared analogously to Example 841:

embedded imagePhase sequenceT*(N,I)/No.R1R2T/° C.Δε*° C.842CH3CH3843CH3C2H5844CH3n-C3H7845C2H5CH3846C2H5C2H5847C2H5n-C3H7848n-C3H7CH3849n-C3H7C2H5850n-C3H7n-C3H7851n-C3H7n-C5H11852n-C5H11n-C3H7853n-C5H11n-C5H11854CH2═CHCH3855CH2═CHC2H5856CH2═CHn-C3H7857CH2═CHCH2═CH858CH3CH2═CH859C2H5CH2═CH860n-C3H7CH2═CH861E-CH3—CH═CHCH2═CH862E-CH3—CH═CHE-CH3—CH═CH863CH3CH3O864CH3C2H5O865CH3n-C3H7O866n-C3H7CH3O867n-C3H7C2H5O868an-C3H7n-C3H7O868bn-C5H11n-C4H9O868cn-C4H9On-C5H11869CH3OCH3O841C2H5OH870C2H5OC2H5O871n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Example 872
(8-Ethoxy-4,7-difluoro-3-(trans-4-vinylcyclohexylmethoxy)-6H-benzo[c]chromene)
872.1 Preparation of 8-ethoxy-4,7-difluoro-3-hydroxy-6H-benzo[c]chromene



embedded image


2.00 g (5.24 mmol) of 3-benzyloxy-8-ethoxy-4,7-difluoro-6H-benzo[c]chromen-6-one, the compound of Example 841, were dissolved in 12 ml of THF, and 2.37 ml (23.0 mmol) of boron trifluoride/THF complex were added with ice-cooling. 24 ml of ethylene glycol dimethyl ether and then in portions 530 mg of sodium borohydride were subsequently added. The mixture was subsequently stirred at room temperature for 18 hours and then transferred onto ice. The mixture was subjected to conventional purification, giving 1.5 g (78% of theory) of 3-benzyloxy-8-ethoxy-4,7-difluoro-6H-benzo[c]chromene as colourless crystals. These were dissolved in THF, hydrogenated at a pressure of 1 bar in the presence of 0.6 g of Pd/C (5%), filtered and evaporated, giving 1.2 g (99% of theory) of 8-ethoxy-4,7-difluoro-3-hydroxy-6H-benzo[c]chromene as colourless crystals.


872.2 Preparation of 8-ethoxy-4,7-difluoro-3-(trans-4-vinylcyclohexyl-methoxy)-6H-benzo[c]chromene



embedded image


1.2 g (4.32 mmol) of 8-ethoxy4,7-difluoro-3-hydroxy-6H-benzo[c]-chromene, 2.16 g (8.64 mmol) of (trans-4-vinylcyclohexyl)methyl iodide and 650 mg (5 mmol) of potassium carbonate were refluxed for 16 hours in 15 ml of acetone. The mixture was then -transferred into MTB ether and subjected to conventional purification, giving 460.mg (27% of theory) of 8-ethoxy-4,7-difluoro-3-(trans-4-vinylcyclohexylmethoxy)-6 H-benzo[c]-chromene as colourless crystals.


Examples 873-902

The following are prepared analogously to Example 872:

embedded imagePhase sequenceT*(N,I)/No.R1R2T/° C.Δε*° C.873CH3CH3874CH3C2H5875CH3n-C3H7876C2H5CH3877C2H5C2H5878C2H5n-C3H7879n-C3H7CH3880n-C3H7C2H5881n-C3H7n-C3H7882n-C3H7n-C5H11883n-C5H11n-C3H7884n-C5H11n-C5H11885CH2═CHCH3886CH2═CHC2H5887CH2═CHn-C3H7872CH2═CHC2H5OC 123 N 167 I−10.4207888CH2═CHCH2═CH889CH3CH2═CH890C2H5CH2═CH891n-C3H7CH2═CH892E-CH3—CH═CHCH2═CH893E-CH3—CH═CHE-CH3—CH═CH894CH3CH3O895CH3C2H5O896CH3n-C3H7O897n-C3H7CH3O898n-C3H7C2H5O899an-C3H7n-C3H7O899bn-C5H11n-C4H9OC 109 SA 157 N−11.2199167.5 I899cn-C4H9On-C5H11900CH3OCH3O901C2H5OC2H5O902n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Examples 903 to 934

The following are prepared analogously to Example 241 and Example 361 a:

embedded imagePhase sequenceNo.R1R2T/° C.Δε*903CH3CH3904CH3C2H5905CH3n-C3H7906C2H5CH3907C2H5C2H5908C2H5n-C3H7909n-C3H7CH3910n-C3H7C2H5911n-C3H7n-C3H7912n-C3H7n-C5H11913n-C5H11n-C3H7914n-C5H11n-C5H11915CH2═CHCH3916CH2═CHC2H5917CH2═CHn-C3H7918CH2═CHCH2═CH919CH3CH2═CH920C2H5CH2═CH921n-C3H7CH2═CH922E-CH3—CH═CHCH2═CH923E-CH3—CH═CHE-CH3—CH═CH924CH3CH3O925CH3C2H5O926CH3n-C3H7O927n-C3H7CH3O928n-C3H7C2H5O929n-C3H7n-C3H7O930n-C5H11n-C4H9O931n-C4H9On-C5H11932CH3OCH3O933C2H5OC2H5O934n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Examples 935 to 966

The following are prepared analogously to Example 241 and Example 361a:

embedded imagePhase sequenceNo.R1R2T/° C.Δε*935CH3CH3936CH3C2H5937CH3n-C3H7938C2H5CH3939C2H5C2H5940C2H5n-C3H7941n-C3H7CH3942n-C3H7C2H5943n-C3H7n-C3H7944n-C3H7n-C5H11945n-C5H11n-C3H7946n-C5H11n-C5H11947CH2═CHCH3948CH2═CHC2H5949CH2═CHn-C3H7950CH2═CHCH2═CH951CH3CH2═CH952C2H5CH2═CH953n-C3H7CH2═CH954E-CH3—CH═CHCH2═CH955E-CH3—CH═CHE-CH3—CH═CH956CH3CH3O957CH3C2H5O958CH3n-C3H7O959n-C3H7CH3O960n-C3H7C2H5O961n-C3H7n-C3H7O962n-C5H11n-C4H9O963n-C4H9On-C5H11964CH3OCH3O965C2H5OC2H5O966n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Examples 967 to 998

The following are prepared analogously to Example 241 and Example 361a:

embedded imagePhase sequenceNo.R1R2T/° C.Δε*967CH3CH3968CH3C2H5969CH3n-C3H7970C2H5CH3971C2H5C2H5972C2H5n-C3H7973n-C3H7CH3974n-C3H7C2H5975n-C3H7n-C3H7976n-C3H7n-C5H11977n-C5H11n-C3H7978n-C5H11n-C5H11979CH2═CHCH3980CH2═CHC2H5981CH2═CHn-C3H7982CH2═CHCH2═CH983CH3CH2═CH984C2H5CH2═CH985n-C3H7CH2═CH986E-CH3—CH═CHCH2═CH987E-CH3—CH═CHE-CH3—CH═CH988CH3CH3O989CH3C2H5O990CH3n-C3H7O991n-C3H7CH3O992n-C3H7C2H5O993n-C3H7n-C3H7O994n-C5H11n-C4H9O995n-C4H9On-C5H11996CH3OCH3O997C2H5OC2H5O998n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Examples 999 to 1030

The following are prepared analogously to Example 241 and Example 361 a:

embedded imagePhase sequenceNo.R1R2T/° C.Δε* 999CH3CH31000CH3C2H51001CH3n-C3H71002C2H5CH31003C2H5C2H51004C2H5n-C3H71005n-C3H7CH31006n-C3H7C2H51007n-C3H7n-C3H71008n-C3H7n-C5H111009n-C5H11n-C3H71010n-C5H11n-C5H111011CH2═CHCH31012CH2═CHC2H51013CH2═CHn-C3H71014CH2═CHCH2═CH1015CH3CH2═CH1016C2H5CH2═CH1017n-C3H7CH2═CH1018E-CH3—CH═CHCH2═CH1019E-CH3—CH═CHE-CH3—CH═CH1020CH3CH3O1021CH3C2H5O1022CH3n-C3H7O1023n-C3H7CH3O1024n-C3H7C2H5O1025n-C3H7n-C3H7O1026n-C5H11n-C4H9OC 187 SA 230N 230.4 I1027n-C4H9On-C5H111028CH3OCH3O1029C2H5OC2H5O1030n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Examples 1031 to 1062

The following are prepared analogously to Example 241 and Example 361 a:

embedded imagePhase sequenceNo.R1R2T/° C.Δε*1031CH3CH31032CH3C2H51033CH3n-C3H71034C2H5CH31035C2H5C2H51036C2H5n-C3H71037n-C3H7CH31038n-C3H7C2H51039n-C3H7n-C3H71040n-C3H7n-C5H111041n-C5H11n-C3H71042n-C5H11n-C5H111043CH2═CHCH31044CH2═CHC2H51045CH2═CHn-C3H71046CH2═CHCH2═CH1047CH3CH2═CH1048C2H5CH2═CH1049n-C3H7CH2═CH1050E-CH3—CH═CHCH2═CH1051E-CH3—CH═CHE-CH3—CH═CH1052CH3CH3O1053CH3C2H5O1054CH3n-C3H7O1055n-C3H7CH3O1056n-C3H7C2H5O1057n-C3H7n-C3H7O1058n-C5H11n-C5H11OC 151 SB 188SA 191 I1059n-C4H9On-C5H111060CH3OCH3O1061C2H5OC2H5O1062n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Examples 1063 to 1093

The following are prepared analogously to Example 241 and Example 361 a:

embedded imagePhase sequenceNo.R1R2T/° C.Δε*1063CH3CH31064CH3C2H51065CH3n-C3H71066C2H5CH31067C2H5C2H51068C2H5n-C3H71069n-C3H7CH31070n-C3H7C2H51071n-C3H7n-C3H71072n-C3H7n-C5H111073n-C5H11n-C3H71074n-C5H11n-C5H111075CH2═CHCH31076CH2═CHC2H51077CH2═CHn-C3H71078CH2═CHCH2═CH1079CH3CH2═CH1080C2H5CH2═CH1081n-C3H7CH2═CH1082E-CH3—CH═CHCH2═CH1083E-CH3—CH═CHE-CH3—CH═CH1084CH3CH3O1085CH3C2H5O1086CH3n-C3H7O1087n-C3H7CH3O1088n-C3H7C2H5O1089n-C3H7n-C3H7O1090n-C4H9On-C5H111091CH3OCH3O1092C2H5OC2H5O1093n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Examples 1094 to 1125

The following are prepared analogously to Example 241 and Example 361 a:

embedded imagePhase sequenceNo.R1R2T/° C.Δε*1094CH3CH31095CH3C2H51096CH3n-C3H71097C2H5CH31098C2H5C2H51099C2H5n-C3H71100n-C3H7CH31101n-C3H7C2H51102n-C3H7n-C3H71103n-C3H7n-C5H111104n-C5H11n-C3H71105n-C5H11n-C5H111106CH2═CHCH31107CH2═CHC2H51108CH2═CHn-C3H71109CH2═CHCH2═CH1110CH3CH2═CH1111C2H5CH2═CH1112n-C3H7CH2═CH1113E-CH3—CH═CHCH2═CH1114E-CH3—CH═CHE-CH3—CH═CH1115CH3CH3O1116CH3C2H5O1117CH3n-C3H7O1118n-C3H7CH3O1119n-C3H7C2H5O1120n-C3H7n-C3H7O1121n-C5H11n-C4H9O1122n-C4H9On-C5H111123CH3OCH3O1124C2H5OC2H5O1125n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Examples 1126 to 1157

The following are prepared analogously to Example 241 and Example 361 a:

embedded imagePhase sequenceNo.R1R2T/° C.Δε*1126CH3CH31127CH3C2H51128CH3n-C3H71129C2H5CH31130C2H5C2H51131C2H5n-C3H71132n-C3H7CH31133n-C3H7C2H51134n-C3H7n-C3H71135n-C3H7n-C5H111136n-C5H11n-C3H71137n-C5H11n-C5H111138CH2═CHCH31139CH2═CHC2H51140CH2═CHn-C3H71141CH2═CHCH2═CH1142CH3CH2═CH1143C2H5CH2═CH1144n-C3H7CH2═CH1145E-CH3—CH═CHCH2═CH1146E-CH3—CH═CHE-CH3—CH═CH1147CH3CH3O1148CH3C2H5O1149CH3n-C3H7O1150n-C3H7CH3O1151n-C3H7C2H5O1152n-C3H7n-C3H7O1153n-C5H11n-C4H9O1154n-C4H9On-C5H111155CH3OCH3O1156C2H5OC2H5O1157n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Examples 1158 to 1190

The following are prepared analogously to Example 241 and Example 361 a:

embedded imagePhase sequenceNo.R1R2T/° C.Δε*1158CH3CH31159CH3C2H51160CH3n-C3H71161C2H5CH31162C2H5C2H51163C2H5n-C3H71154n-C3H7CH31165n-C3H7C2H51166n-C3H7n-C3H71167n-C3H7n-C5H111168n-C5H11n-C3H71159n-C5H11n-C5H111170CH2═CHCH31171CH2═CHC2H51172CH2═CHn-C3H71173CH2═CHCH2═CH1174CH3CH2═CH1175C2H5CH2═CH1176n-C3H7CH2═CH1177E-CH3—CH═CHCH2═CH1178E-CH3—CH═CHE-CH3—CH═CH1179CH3CH3O1180CH3C2H5O1181CH3n-C3H7O1182n-C3H7CH3O1183n-C3H7C2H5O1184n-C3H7n-C3H7O1185n-C5H11n-C4H9O1186n-C4H9On-C5H111187CH3OCH3O1188C2H5OC2H5O1190n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Examples 1191 to 1222

The following are prepared analogously to Example 241 and Example 361a:

embedded imagePhase sequenceNo.R1R2T/° C.Δε*1191CH3CH31192CH3C2H51193CH3n-C3H71194C2H5CH31195C2H5C2H51196C2H5n-C3H71197n-C3H7CH31198n-C3H7C2H51199n-C3H7n-C3H71200n-C3H7n-C5H111201n-C5H11n-C3H71202n-C5H11n-C5H111203CH2═CHCH31204CH2═CHC2H51205CH2═CHn-C3H71206CH2═CHCH2═CH1207CH3CH2═CH1208C2H5CH2═CH1209n-C3H7CH2═CH1200E-CH3—CH═CHCH2═CH1211E-CH3—CH═CHE-CH3—CH═CH1212CH3CH3O1213CH3C2H5O1214CH3n-C3H7O1215n-C3H7CH3O1216n-C3H7C2H5O1217n-C3H7n-C3H7O1218n-C5H11n-C4H9O1219n-C4H9On-C5H111220CH3OCH3O1221C2H5OC2H5O1222n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Examples 1223 to 1254

The following are prepared analogously to Example 241 and Example 361a;

embedded imagePhase sequenceNo.R1R2T/° C.Δε*1223CH3CH31224CH3C2H51225CH3n-C3H71226C2H5CH31227C2H5C2H51228C2H5n-C3H71229n-C3H7CH31230n-C3H7C2H51231n-C3H7n-C3H71232n-C3H7n-C5H111233n-C5H11n-C3H71234n-C5H11n-C5H111235CH2═CHCH31236CH2═CHC2H51237CH2═CHn-C3H71238CH2═CHCH2═CH1239CH3CH2═CH1240C2H5CH2═CH1241n-C3H7CH2═CH1242E-CH3—CH═CHCH2═CH1243E-CH3—CH═CHE-CH3—CH═CH1244CH3CH3O1245CH3C2H5O1246CH3n-C3H7O1247n-C3H7CH3O1248n-C3H7C2H5O1249n-C3H7n-C3H7O1250n-C5H11n-C4H9O1251n-C4H9On-C5H111252CH3OCH3O1253C2H5OC2H5O1254n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Examples 1255 to 1286

The following are prepared analogously to Example 241 and Example 361a:

embedded imagePhase sequenceNo.R1R2T/° C.Δε*1255CH3CH31256CH3C2H51257CH3n-C3H71258C2H5CH31259C2H5C2H51260C2H5n-C3H71261n-C3H7CH31262n-C3H7C2H51263n-C3H7n-C3H71264n-C3H7n-C5H111265n-C5H11n-C3H71266n-C5H11n-C5H111267CH2═CHCH31268CH2═CHC2H51269CH2═CHn-C3H71270CH2═CHCH2═CH1271CH3CH2═CH1272C2H5CH2═CH1273n-C3H7CH2═CH1274E-CH3—CH═CHCH2═CH1275E-CH3—CH═CHE-CH3—CH═CH1276CH3CH3O1277CH3C2H5O1278CH3n-C3H7O1279n-C3H7CH3O1280n-C3H7C2H5O1281n-C3H7n-C3H7O1252n-C5H11n-C4H9O1283n-C4H9On-C5H111284CH3OCH3O1285C2H5OC2H5O1286n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Examples 1287 to 1318

The following are prepared analogously to Example 241 and Example 361a:

embedded imagePhase sequenceNo.R1R2T/° C.Δε*1287CH3CH31288CH3C2H51289CH3n-C3H71290C2H5CH31291C2H5C2H51292C2H5n-C3H71293n-C3H7CH31294n-C3H7C2H51295n-C3H7n-C3H71296n-C3H7n-C5H111297n-C5H11n-C3H71298n-C5H11n-C5H111299CH2═CHCH31300CH2═CHC2H51301CH2═CHn-C3H71302CH2═CHCH2═CH1303CH3CH2═CH1304C2H5CH2═CH1305n-C3H7CH2═CH1306E-CH3—CH═CHCH2═CH1307E-CH3—CH═CHE-CH3—CH═CH1308CH3CH3O1309CH3C2H5O1310CH3n-C3H7O1311n-C3H7CH3O1312n-C3H7C2H5O1313n-C3H7n-C3H7O1314n-C5H11n-C4H9O1315n-C4H9On-C5H111316CH3OCH3O1317C2H5OC2H5O1318n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Examples 1319 to 1350

The following are prepared analogously to Example 241 and Example 361a:

embedded imagePhase sequenceNo.R1R2T/° C.Δε*1319CH3CH31320CH3C2H51321CH3n-C3H71322C2H5CH31323C2H5C2H51324C2H5n-C3H71325n-C3H7CH31326n-C3H7C2H51327n-C3H7n-C3H71328n-C3H7n-C5H111329n-C5H11n-C3H71330n-C5H11n-C5H111331CH2═CHCH31332CH2═CHC2H51333CH2═CHn-C3H71334CH2═CHCH2═CH1335CH3CH2═CH1336C2H5CH2═CH1337n-C3H7CH2═CH1338E-CH3—CH═CHCH2═CH1339E-CH3—CH═CHE-CH3—CH═CH1340CH3CH3O1341CH3C2H5O1342CH3n-C3H7O1343n-C3H7CH3O1344n-C3H7C2H5O1345n-C3H7n-C3H7O1346n-C5H11n-C4H9OC 112 SA 149 I−8.11347n-C4H9On-C5H111348CH3OCH3O1349C2H5OC2H5O1350n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Examples 1351 to 1382

The following are prepared analogously to Example 241 and Example 361a:

embedded imagePhase sequenceNo.R1R2T/° C.Δε*1351CH3CH31352CH3C2H51353CH3n-C3H71354C2H5CH31355C2H5C2H51356C2H5n-C3H71357n-C3H7CH31358n-C3H7C2H51359n-C3H7n-C3H71360n-C3H7n-C5H111361n-C5H11n-C3H71362n-C5H11n-C5H111363CH2═CHCH31364CH2═CHC2H51365CH2═CHn-C3H71366CH2═CHCH2═CH1367CH3CH2═CH1368C2H5CH2═CH1369n-C3H7CH2═CH1370E-CH3—CH═CHCH2═CH1371E-CH3—CH═CHE-CH3—CH═CH1372CH3CH3O1373CH3C2H5O1374CH3n-C3H7O1375n-C3H7CH3O1376n-C3H7C2H5O1377n-C3H7n-C3H7O1378n-C5H11n-C4H9O1379n-C4H9On-C5H111380CH3OCH3O1381C2H5OC2H5O1382n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Examples 1383 to 1385

The following are prepared analogously to Example 241 and Example 361a:

embedded imagePhase sequenceNo.R1R2T/° C.Δε*1383CH3CH31384CH3C2H51385CH3n-C3H71386C2H5CH31387C2H5C2H51388C2H5n-C3H71389n-C3H7CH31390n-C3H7C2H51391n-C3H7n-C3H71392n-C3H7n-C5H111393n-C5H11n-C3H71394n-C5H11n-C5H111395CH2═CHCH31396CH2═CHC2H51397CH2═CHn-C3H71398CH2═CHCH2═CH1399CH3CH2═CH1400C2H5CH2═CH1401n-C3H7CH2═CH1402E-CH3—CH═CHCH2═CH1403E-CH3—CH═CHE-CH3—CH═CH1404CH3CH3O1405CH3C2H5O1406CH3n-C3H7O1407n-C3H7CH3O1408n-C3H7C2H5O1409n-C3H7n-C3H7O1410n-C5H11n-C4H9O1411n-C4H9On-C5H111412CH3OCH3O1413C2H5OC2H5O1414n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Examples 1415 to 1446

The following are prepared analogously to Example 241 and Example 361a:

embedded imagePhase sequenceNo.R1R2T/° C.Δε*1415CH3CH31416CH3C2H51417CH3n-C3H71418C2H5CH31419C2H5C2H51420C2H5n-C3H71421n-C3H7CH31422n-C3H7C2H51423n-C3H7n-C3H71424n-C3H7n-C5H111425n-C5H11n-C3H71426n-C5H11n-C5H111427CH2═CHCH31428CH2═CHC2H51429CH2═CHn-C3H71430CH2═CHCH2═CH1431CH3CH2═CH1432C2H5CH2═CH1433n-C3H7CH2═CH1434E-CH3—CH═CHCH2═CH1435E-CH3—CH═CHE-CH3—CH═CH1436CH3CH3O1437CH3C2H5O1438CH3n-C3H7O1439n-C3H7CH3O1440n-C3H7C2H5O1441n-C3H7n-C3H7O1442n-C5H11n-C4H9O1443n-C4H9On-C5H111444CH3OCH3O1445C2H5OC2H5O1446n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Examples 1447 to 1478

The following are prepared analogously to Example 241 and Example 361a:

embedded imagePhase sequenceNo.R1R2T/° C.Δε*1447CH3CH31448CH3C2H51449CH3n-C3H71450C2H5CH31451C2H5C2H51452C2H5n-C3H71453n-C3H7CH31454n-C3H7C2H51455n-C3H7n-C3H71456n-C3H7n-C5H111457n-C5H11n-C3H71458n-C5H11n-C5H111459CH2═CHCH31460CH2═CHC2H51461CH2═CHn-C3H71462CH2═CHCH2═CH1463CH3CH2═CH1464C2H5CH2═CH1465n-C3H7CH2═CH1466E-CH3—CH═CHCH2═CH1467E-CH3—CH═CHE-CH3—CH═CH1468CH3CH3O1469CH3C2H5O1470CH3n-C3H7O1471n-C3H7CH3O1472n-C3H7C2H5O1473n-C3H7n-C3H7O1474n-C5H11n-C4H9O1475n-C4H9On-C5H111476CH3OCH3O1477C2H5OC2H5O1478n-C3H7On-C3H7O
Note

*values extrapolated from 10% solution in ZLI-4792 or ZLI-2857 (Δε).


Mixture Examples

Liquid-crystalline mixtures are prepared and their applicational properties are investigated.


Example M-1

A liquid-crystal mixture having the composition indicated in the following table was prepared and investigated. It has the properties likewise shown in the table.

CompositionCompoundAbbre-Conc./%#viationby wt.Physical properties1PCH-3019.0T(N, I) =65.9° C.2PCH-3029.0ε⊥(20° C., 1 kHz) >6.13CCH-30129.7Δε(20° C., 1 kHz) >−2.34CCN-479.95CCN-559.06CBC-33F4.57CBC-53F4.58CBC-55F4.59CBC-334.510CBC-535.411BFFO-3-5FF10.0Σ100.0


The liquid-crystal medium has very good applicational properties.


Example M-2

A liquid-crystal mixture having the composition indicated in the following table was prepared and investigated. It has the properties likewise shown in the table.

CompositionCom-poundAbbre-Conc./%#viationby wt.Physical properties1PCH-3019.0T(N, I) =76.9° C.2PCH-3029.0ε⊥(20° C., 1 kHz) >5.43CCH-30129.7Δε(20° C., 1 kHz) >−1.94CCN-479.95CCN-559.06CBC-33F4.57CBC-53F4.58CBC-55F4.59CBC-334.510CBC-535.411BHHO-3O-5FF10.0Σ100.0


The liquid-crystal medium has very good applicational properties.


Example M-3

The mixture shown in the following table is prepared and investigated.

CompositionCom-poundAbbre-Conc./%#viationby wt.Physical properties1PCH-304FF16.0T(N, I) =70° C.2PCH-502FF8.0Δn(20° C., 589 nm) =0.1003PCH-504FF14.0Δε(20° C., 1 kHz) >−4.54CCP-302FF14.05CCP-502FF12.06CCH-356.07CC-3-V18.08CCP-V-18.09BCH-328.010BFFO-3-5FF3.011BHHO-20-5FF3.0Σ100.0


The liquid-crystal medium has excellent applicational properties.


Example M-4

The mixture shown in the following table is prepared and investigated.

CompositionCom-poundAbbre-Conc./%#viationby wt.Physical properties1PCH-304FF7.0T(N, I) =95.5°C.2CCP-402FF2.0Δn (20° C., 5890.128nm) =3CCP-303FF7.0Δε (20° C., 1−3.2kHz) >4BCH-202FF11.0k1 (20° C.) =16.0pN5BCH-302FF11.0k1/k3 (20° C.) =0.946PYP-2-310.0γ1 (20° C.) =154mPa · s7PYP-2-410.0tstore (−20° C.) >1,000h8CC-4-V10.0V0 (20° C.) =2.28V9CC-5-V10.010CC-3-V110.011CCP-V-12.012CCH-345.013C-BHHO-3.05-04FFΣ100.0


The liquid-crystal medium has excellent applicational properties, as is evident, for example,in comparison with the following comparative example (CM-1).


Comparative Example CM-1

The mixture shown in the following table, which comprises no compound according to the invention, is prepared and investigated.

CompositionCom-poundAbbre-Conc./%#viationby wt.Physical properties1PCH-304FF12.0T(N, I) =96°C.2PCH-502FF10.0Δn (20° C., 5890.126nm) =3BCH-202FF12.0Δε (20° C., 1−3.1kHz) >4BCH-302FF13.0k1 (20° C.) =15.0pN5PYP-2-38.0k1/k3 (20° C.) =1.096PYP-2-48.0γ1 (20° C.) =169mPa · s7CC-4-V13.0tstore (−20° C.) >1,000h8CC-3-V19.0V0 (20° C.) =2.42V9CCP-V-110.010CCPC-333.011CCPC-343.0Σ100.0


The liquid-crystal medium has similar values for the clearing point, the birefringence and the dielectric anisotropy to the medium of Example 4. However, it has significantly higher rotational viscosity and at the same time a higher threshold voltage and consequently has clearly inferior applicational properties.


Example M-5

The mixture shown in the following table is prepared and investigated.

CompositionCom-poundAbbre-Conc./%#viationby wt.Physical properties1PCH-304FF5.0T(N, I) =95.5°C.2PCH-502FF3.0Δn (20° C., 5890.129nm) =3CCP-303FF10.0Δε (20° C., 1−3.8kHz) >4BCH-202FF11.0k1 (20° C.) =15.7pN5BCH-302FF11.0k1/k3 (20° C.) =0.976PYP-2-36.0γ1 (20° C.) =173mPa · s7PYP-2-414.0tstore (−20° C.) >1,000h8CC-4-V15.0V0 (20° C.) =2.10V9CC-3-V112.010CCH-346.011C-BHHO-7.05-04FFΣ100.0


The liquid-crystal medium has excellent applicational properties, as is evident, for example, in comparison with the following comparative example (CM-2).


Comparative Example CM-2

The mixture shown in the following table, which comprises no compound according to the invention, is prepared and investigated.

CompositionCom-Conc./%poundAbbre-by#viationwtPhysical properties1PCH-304FF9.0T(N, I) =96°C.2PCH-502FF5.0Δn (20° C., 5890.1127nm) =3CCP-302FF8.0Δε (20° C., 1−3.7kHz) >4CCP-402FF9.0k1 (20° C.) =16.3pN5BCH-2-02FF12.0k1/k3 (20° C.) =0.976BCH-3-02FF12.0γ1 (20° C.) =179mPa · s7PYP-2-39.0tstore (−20° C.) =950h8PYP-2-49.0V0 (20° C.) =2.19V9CC-4-V13.010CC-3-V111.011CCH-352.0Σ100.0


The liquid-crystal medium has similar values for the clearing point, the birefringence and the dielectric anisotropy to the medium of Example 5. However, it has significantly higher rotational viscosity and at the same time a higher threshold voltage and consequently has less suitable applicational properties.

Claims
  • 1. Compound of the formula I
  • 2. Compound of the formula I according to claim 1, selected from the group consisting of the compounds of the formulae I-1a to I-3b
  • 3. Compound according to claim 1, characterised in that Y is —CF2—.
  • 4. Compound according to claim 1, characterised in that L1 and L2 are both F.
  • 5. Compound according to claim 1, characterised in that Z1 and Z2 are both a single bond.
  • 6. Liquid-crystal medium, characterised in that it comprises one or more compounds of the formula I as defined in claim 1.
  • 7. Liquid-crystal medium, characterised in that it has a nematic phase and comprises one or more compounds of the formula I as defined in claim 1, but in which L1 and L2 can both be H even if Y is —CO—, in contrast to the definition in claim 1.
  • 8. Liquid-crystal medium according to claim 6, characterised in that it comprises one or more dielectrically negative compound(s) of the formula II in which R21 and R22 are each, independently of one another, as defined for R1 and R2 under the formula I, Z21 and Z22 are each, independently of one another, as defined for Z1 and Z2 under the formula I, are each, independently of one another, L1 and L2 are both C—F or one of the two is N and the other is C—F, and I is 0 or 1.
  • 9. Liquid-crystal medium according to claim 6, characterised in that it comprises one or more compound(s) of the formula II-1
  • 10. Use of a liquid-crystal medium according to claim 6 in an electro-optical display.
  • 11. Electro-optical display containing a liquid-crystal medium according to claim 6.
  • 12. Display according to claim 11, characterised in that it is a VAN LCD.
Priority Claims (1)
Number Date Country Kind
103-08-266.2 Feb 2003 DE national
PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/EP04/00731 1/28/2004 WO 8/24/2005